Nothing Special   »   [go: up one dir, main page]

KR20110085891A - Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device - Google Patents

Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device Download PDF

Info

Publication number
KR20110085891A
KR20110085891A KR1020110003538A KR20110003538A KR20110085891A KR 20110085891 A KR20110085891 A KR 20110085891A KR 1020110003538 A KR1020110003538 A KR 1020110003538A KR 20110003538 A KR20110003538 A KR 20110003538A KR 20110085891 A KR20110085891 A KR 20110085891A
Authority
KR
South Korea
Prior art keywords
liquid crystal
solution
crystal aligning
polyamic acid
dianhydride
Prior art date
Application number
KR1020110003538A
Other languages
Korean (ko)
Other versions
KR101798375B1 (en
Inventor
유우코 이누카이
켄이치 이즈미
카츠히로 우치야마
타카히토 카토우
Original Assignee
제이에스알 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이에스알 가부시끼가이샤 filed Critical 제이에스알 가부시끼가이샤
Publication of KR20110085891A publication Critical patent/KR20110085891A/en
Application granted granted Critical
Publication of KR101798375B1 publication Critical patent/KR101798375B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1003Preparatory processes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/50Physical properties
    • C08G2261/53Physical properties liquid-crystalline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

PURPOSE: A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device are provided to secure the excellent preserving stability of the liquid crystal alignment agent. CONSTITUTION: A liquid crystal alignment agent contains at least one polymer selected from the group consisting of polyamic acid obtained by reacting tetracarboxylic dianhydride and diamine, and a polyimide obtained by dehydrate-cyclizing the polyamic acid. The tetracarboxylic dianhydride contains 5~80mol% of one compound selected from 1S,2S,4R,5R-cyclohexanetetracarboxylic dianhydride and 1S,2S,4S,5R-cyclohexanetetracarboxylic dianhydride.

Description

액정 배향제, 액정 배향막 및 액정 표시 소자 {LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE}Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element {LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE}

본 발명은, 액정 배향제 및 액정 표시 소자에 관한 것이다. 더욱 상세하게는, 보존 안정성이 우수하고, 특히 내열성이 우수한 액정 배향제 및, 고품위의 표시가 가능하고, 열(熱)스트레스에 의한 표시 열화가 억제되어, 장시간 구동이 가능한 액정 표시 소자에 관한 것이다. This invention relates to a liquid crystal aligning agent and a liquid crystal display element. In more detail, it is related with the liquid crystal aligning agent which is excellent in storage stability, especially the heat resistance, and high quality display is possible, the display deterioration by heat stress is suppressed, and can drive for a long time. .

액정 표시 소자에 이용되는 액정 배향막의 재료는, 폴리이미드, 폴리아미드, 폴리암산, 폴리에스테르 등의 수지 재료가 알려져 있다. 그 중에서도 폴리암산 또는 폴리이미드로 이루어지는 액정 배향막은 내열성, 기계적 강도, 액정과의 친화성 등이 우수하여, 많은 액정 표시 소자에 사용되고 있다(특허문헌 1∼6). As a material of the liquid crystal aligning film used for a liquid crystal display element, resin materials, such as a polyimide, a polyamide, a polyamic acid, and polyester, are known. Especially, the liquid crystal aligning film which consists of polyamic acid or polyimide is excellent in heat resistance, mechanical strength, affinity with a liquid crystal, etc., and is used for many liquid crystal display elements (patent documents 1-6).

이 중 폴리암산은, 범용의 유기 용매에 대한 용해성이 높기 때문에, 액정 표시 소자의 제조 공정에 있어서의 인쇄 공정이 용이한 액정 배향제를 얻을 수 있고, 그리고 수지 가격이 저렴하다는 이점이 있다. 그러나, 폴리암산으로 이루어지는 액정 배향막을 갖는 액정 표시 소자는 열스트레스에 취약하여, 액정 표시 소자를 장시간 구동했을 때에, 액정 배향막의 열화에 의한 전압 보전율의 저하가 문제가 되고 있다. 최근에는, 액정 텔레비전으로 대표되는 바와 같이 액정 표시 소자의 수명이 10년을 넘는 것을 전제로 설계된다. 그 때문에, 액정 표시 소자를 장시간 구동한 경우에도 고품위의 표시를 유지하기 위해 장시간 안정된 전압 보전율을 나타내는 것이 중요해져, 배향막의 내열 신뢰성의 향상이 급무가 되고 있다. 지금까지 알려져 있는 배향막의 내열 신뢰성(열스트레스 내성)을 향상하는 방법으로서는, 액정 배향제에 에폭시 화합물을 배합함으로써 액정 배향막의 화학적 안정성을 증가시키는 방법(특허문헌 7), 카본산을 갖는 모너머를 도입한 폴리암산을 적용함으로써 액정 배향막의 소성시에 분자 간 가교를 형성하여, 이에 따라 막의 안정성을 증가시키는 방법(특허문헌 8) 등이 제안되고 있다. 그러나, 이들 기술에 의하면, 소기의 성능을 발휘하기 위해서는 에폭시 화합물 또는 카본산을 다량으로 사용하는 것이 필요하고, 액정 배향막의 리워크성(액정 배향제의 인쇄 불량시의 도막 박리의 용이성), 러빙 내성 등이 손상되는 경우가 있어, 추가적인 개선을 요한다. Among these, since polyamic acid has high solubility in a general organic solvent, there exists an advantage that the liquid crystal aligning agent which is easy in the printing process in the manufacturing process of a liquid crystal display element can be obtained, and resin price is low. However, the liquid crystal display element which has the liquid crystal aligning film which consists of polyamic acid is vulnerable to heat stress, and when the liquid crystal display element is driven for a long time, the fall of the voltage holding ratio by deterioration of a liquid crystal aligning film becomes a problem. In recent years, it is designed on the premise that the lifetime of a liquid crystal display element exceeds 10 years, as represented by a liquid crystal television. Therefore, even when the liquid crystal display element is driven for a long time, in order to maintain high quality display, it is important to exhibit a stable voltage holding ratio for a long time, and the improvement of the heat resistance reliability of the alignment film is suddenly increasing. As a method of improving the heat resistance reliability (heat stress resistance) of the alignment film known so far, the method of increasing the chemical stability of a liquid crystal aligning film by mix | blending an epoxy compound with a liquid crystal aligning agent (patent document 7), the monomer which has carbonic acid By applying the introduced polyamic acid, a method (patent document 8) or the like has been proposed to form an intermolecular crosslink during firing of the liquid crystal alignment film, thereby increasing the stability of the film. However, according to these techniques, in order to exhibit a desired performance, it is necessary to use a large amount of an epoxy compound or a carboxylic acid, and the rework property of the liquid crystal aligning film (easiness of coating film peeling at the time of poor printing of a liquid crystal aligning agent), rubbing Resistance or the like may be damaged, requiring further improvement.

한편 폴리이미드를 함유하는 액정 배향막은, 얻어지는 액정 배향막의 열스트레스 내성은 비교적 높기는 하지만, 종래 알려져 있는 폴리이미드는 범용의 유기 용매에 대한 용해성이 충분하지 않기 때문에, 액정 배향제의 보존 안정성에 문제를 발생시키는 경우가 있다. On the other hand, the liquid crystal aligning film containing a polyimide has relatively high heat stress resistance of the obtained liquid crystal aligning film, but since the conventionally known polyimide does not have sufficient solubility in a general purpose organic solvent, it is a problem in the storage stability of a liquid crystal aligning agent. May be generated.

이러한 사정 하에, 범용의 유기 용매에 대하여 충분한 용해성을 갖고, 그리고 열스트레스 내성이 우수한 액정 배향막을 형성할 수 있는 폴리암산/폴리이미드계의 액정 배향제가 요구되고 있다. Under such circumstances, there is a demand for a polyamic acid / polyimide-based liquid crystal aligning agent capable of forming a liquid crystal aligning film having sufficient solubility in a general purpose organic solvent and excellent in thermal stress resistance.

그러나 최근, 사이클로헥산테트라카본산 무수물을 입체 선택적으로 제조하는 방법이 개발되어, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물을 각각 선택적으로 제조하는 것이 가능해졌다(특허문헌 9, 특허문헌 10 및 비특허문헌 1). 특허문헌 9 및 10에는, 테트라카본산 2무수물로서 상기의 부분입체이성질체(diastereomer)를 각각 100% 이용하여 합성된 폴리암산이 기재되어 있고, 이들이 충분히 높은 분자량을 갖는 폴리머라고 설명되어 있다. 그리고 상기 폴리암산이 액정 표시 소자의 액정 배향막 용도에 사용할 수 있는 것이 기재되어 있기는 하지만, 이들 문헌에 있어서는 액정 배향막의 특성은 하등 측정되어 있지 않고, 원료인 테트라카본산 2무수물의 구조와 얻어지는 액정 배향제의 보존 안정성 및 형성되는 액정 배향막의 열스트레스 내성과의 관련성에 대한 고찰은 전혀 이루어지고 있지 않다. Recently, however, a method for stereoselectively preparing cyclohexanetetracarboxylic acid anhydride has been developed, and 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic acid 2 It became possible to selectively manufacture anhydride, respectively (patent document 9, patent document 10, and nonpatent literature 1). Patent Documents 9 and 10 describe polyamic acids synthesized using 100% of the diastereomers as tetracarboxylic dianhydride, respectively, and are described as polymers having sufficiently high molecular weights. And although it is described that the said polyamic acid can be used for the liquid crystal aligning film use of a liquid crystal display element, in these documents, the characteristic of a liquid crystal aligning film is not measured at all, The structure of the tetracarboxylic dianhydride which is a raw material, and the liquid crystal obtained Consideration has not been given to the relationship between the storage stability of the alignment agent and the thermal stress resistance of the formed liquid crystal alignment film.

일본공개특허공보 평4-153622호Japanese Patent Application Laid-open No. Hei 4-153622 일본공개특허공보 소60-107020호Japanese Laid-Open Patent Publication No. 60-107020 일본공개특허공보 평11-258605호Japanese Patent Application Laid-Open No. 11-258605 일본공개특허공보 소56-91277호Japanese Laid-Open Patent Publication No. 56-91277 미국특허 제5,928,733호 명세서US Patent No. 5,928,733 일본공개특허공보 소62-165628호Japanese Laid-open Patent Publication No. 62-165628 일본공개특허공보 2008-299318호Japanese Laid-Open Patent Publication No. 2008-299318 일본공개특허공보 2009-157351호Japanese Laid-Open Patent Publication No. 2009-157351 일본공개특허공보 2009-191253호Japanese Laid-Open Patent Publication No. 2009-191253 일본공개특허공보 2009-286706호Japanese Laid-Open Patent Publication No. 2009-286706 일본공개특허공보 평6-222366호Japanese Patent Laid-Open No. 6-222366 일본공개특허공보 평6-281937호Japanese Patent Application Laid-open No. Hei 6-281937 일본공개특허공보 평5-107544호Japanese Patent Application Laid-Open No. 5-107544 일본공개특허공보 2010-97188호Japanese Laid-Open Patent Publication No. 2010-97188

일본 고분자학회 예고(豫稿)집, 57권, 2호(2002) Japanese Polymer Society Preliminary Collection, Vol. 57, No. 2 (2002)

본 발명은, 상기의 사정을 감안하여 이루어진 것으로, 그 목적은, 보존 안정성이 우수하고, 액정 표시 소자를 장시간 사용한 경우에도 고품위의 표시를 지속하는 것이 가능한 액정 배향막을 부여하는 액정 배향제를 제공하는 것이다. This invention is made | formed in view of the said situation, The objective is providing the liquid crystal aligning agent which provides the liquid crystal aligning film which is excellent in storage stability and can maintain high quality display, even when using a liquid crystal display element for a long time. will be.

본 발명의 다른 목적은, 장시간 사용한 경우에도 고품위의 표시를 지속하는 것이 가능한 액정 표시 소자를 제공하는 것이다. Another object of the present invention is to provide a liquid crystal display device capable of sustaining high quality display even when used for a long time.

본 발명의 또 다른 목적 및 이점은, 이하의 설명으로부터 분명해질 것이다. Still other objects and advantages of the present invention will become apparent from the following description.

본 발명에 의하면, 본 발명의 상기 목적 및 이점은, 첫 번째로,According to the present invention, the above objects and advantages of the present invention, firstly,

테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제로서,As a liquid crystal aligning agent containing at least 1 sort (s) of polymer chosen from the group which consists of polyamic acid obtained by making tetracarboxylic dianhydride and diamine react, and the polyimide formed by dehydrating and closing the said polyamic acid,

상기 테트라카본산 2무수물이,The tetracarboxylic dianhydride,

1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종을, 전체 테트라카본산 2무수물에 대하여 5∼80몰% 포함하는 상기 액정 배향제에 의해 달성된다. To at least one kind selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic acid dianhydride, with respect to the total tetracarboxylic dianhydride It is achieved by the said liquid crystal aligning agent containing 5-80 mol%.

본 발명의 상기 목적 및 이점은, 두 번째로,The above object and advantages of the present invention, secondly,

상기의 액정 배향제로 형성된 액정 배향막을 구비하는 액정 표시 소자에 의해 달성된다. It is achieved by the liquid crystal display element provided with the liquid crystal aligning film formed from said liquid crystal aligning agent.

본 발명의 액정 배향제는, 보존 안정성이 우수함과 함께, 액정 표시 소자에 이용했을 때에 이것을 장시간 가동시켜도 고품위의 표시를 지속하는 것이 가능한 액정 배향막을 부여한다. 따라서, 이러한 액정 배향제로 형성된 액정 배향막을 구비하는 본 발명의 액정 표시 소자는, 장시간 사용한 경우에도 고품위의 표시를 지속하는 것이 가능하다. While the liquid crystal aligning agent of this invention is excellent in storage stability, when used for a liquid crystal display element, even if it operates for a long time, it provides the liquid crystal aligning film which can sustain the display of high quality. Therefore, the liquid crystal display element of this invention provided with the liquid crystal aligning film formed from such a liquid crystal aligning agent can maintain high quality display, even when it uses for a long time.

본 발명의 액정 표시 소자는 여러 가지 장치에 유효하게 적용할 수 있어, 예를 들면 시계, 휴대형 게임, 워드프로세서, 노트형 퍼스널 컴퓨터, 카 내비게이션 시스템, 캠코더, 휴대 정보 단말, 디지털 카메라, 휴대 전화, 각종 모니터, 액정 텔레비전 등의 표시 장치에 매우 적합하게 이용할 수 있다. The liquid crystal display device of the present invention can be effectively applied to various apparatuses, for example, a clock, a portable game, a word processor, a notebook personal computer, a car navigation system, a camcorder, a portable information terminal, a digital camera, a mobile phone, It can use suitably for display apparatuses, such as various monitors and a liquid crystal television.

(발명을 실시하기 위한 형태)(Form to carry out invention)

본 발명의 액정 배향제는,The liquid crystal aligning agent of this invention,

테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제로서,As a liquid crystal aligning agent containing at least 1 sort (s) of polymer chosen from the group which consists of polyamic acid obtained by making tetracarboxylic dianhydride and diamine react, and the polyimide formed by dehydrating and closing the said polyamic acid,

상기 테트라카본산 2무수물이,The tetracarboxylic dianhydride,

1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종을, 전체 테트라카본산 2무수물에 대하여 5∼80몰% 포함한다. To at least one kind selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic acid dianhydride, with respect to the total tetracarboxylic dianhydride 5 to 80 mol% is included.

이러한 특정의 테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를, 본 명세서 중에서 이하, 「특정 중합체」라고 하는 경우가 있다. At least one polymer selected from the group consisting of polyamic acid obtained by reacting such specific tetracarboxylic dianhydride and diamine and polyimide formed by dehydrating and ring-closing the polyamic acid is hereinafter referred to as "specific polymer" in the present specification. There is a case.

<테트라카본산 2무수물><Tetracarboxylic dianhydride>

본 발명에 있어서의 폴리암산을 합성하기 위한 테트라카본산 2무수물로서는, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종과 그 외의 테트라카본산 2무수물을 병용한다. As tetracarboxylic dianhydride for synthesizing polyamic acid in the present invention, 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic acid dianhydride At least 1 sort (s) chosen from the group which consists of, and other tetracarboxylic dianhydride are used together.

여기에서, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종의 전체 테트라카본산 무수물에 대한 사용 비율은 5∼80몰%이지만, 이것을 10∼60몰% 포함하는 것이 바람직하고, 15∼50몰% 포함하는 것이 더욱 바람직하다. 이 비율이 5몰% 미만인 경우에는 형성되는 액정 배향막의 내열 신뢰성이 떨어지는 경우가 있고, 한편 80몰%를 초과하는 경우에는 얻어지는 액정 배향막의 보존 안정성이 떨어지는 경우가 있기 때문에 바람직하지 않다. Herein, at least one total tetracarboxylic anhydride selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride. Although the use ratio with respect to is 5-80 mol%, it is preferable to contain this 10-60 mol%, and it is more preferable to contain 15-50 mol%. When this ratio is less than 5 mol%, the heat resistance reliability of the liquid crystal aligning film formed may be inferior, and when it exceeds 80 mol%, the storage stability of the liquid crystal aligning film obtained may be inferior.

상기 테트라카본산 2무수물은, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물을 상기의 범위에서 포함하는 것이 보다 바람직하다. As for the said tetracarboxylic dianhydride, it is more preferable that 1S, 2S, 4R, 5R-cyclohexane tetracarboxylic dianhydride is included in said range.

상기 그 외의 테트라카본산 2무수물로서는, 예를 들면 지방족 테트라카본산 2무수물, 지환식 테트라카본산 2무수물, 방향족 테트라카본산 2무수물 등을 들 수 있다. 이들의 구체예로서는, 지방족 테트라카본산 2무수물로서, 예를 들면 부탄테트라카본산 2무수물 등을;As said other tetracarboxylic dianhydride, aliphatic tetracarboxylic dianhydride, alicyclic tetracarboxylic dianhydride, aromatic tetracarboxylic dianhydride, etc. are mentioned, for example. As these specific examples, As an aliphatic tetracarboxylic dianhydride, For example, butanetetracarboxylic dianhydride etc .;

지환식 테트라카본산 2무수물로서, 예를 들면 1,2,3,4-사이클로부탄테트라카본산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물, 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 3-옥사바이사이클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라하이드로푸란-2',5'-디온), 5-(2,5-디옥소테트라하이드로-3-푸라닐)-3-메틸-3-사이클로헥센-1,2-디카본산 무수물, 3,5,6-트리카복시-2-카복시메틸노르보르난-2:3,5:6-2무수물, 2,4,6,8-테트라카복시바이사이클로[3.3.0]옥탄-2:4,6:8-2무수물, 4,9-디옥사트리사이클로[5.3.1.02,6]운데칸-3,5,8,10-테트라온 등을; As alicyclic tetracarboxylic dianhydride, For example, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 2,3,5- tricarboxy cyclopentyl acetic dianhydride, 1,3,3a, 4, 5,9b-hexahydro-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 1,3,3a, 4 , 5,9b-hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 3- Oxabicyclo [3.2.1] octane-2,4-dione-6-spiro-3 '-(tetrahydrofuran-2', 5'-dione), 5- (2,5-dioxotetrahydro-3 -Furanyl) -3-methyl-3-cyclohexene-1,2-dicarboxylic acid anhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornan-2: 3,5: 6-2 anhydride, 2,4,6,8-tetracarboxybicyclo [3.3.0] octane-2: 4,6: 8-2 anhydride, 4,9-dioxatricyclo [5.3.1.0 2,6 ] undecane-3 , 5,8,10-tetraon and the like;

방향족 테트라카본산 2무수물로서, 예를 들면 피로멜리트산 2무수물 등을 각각 들 수 있는 것 외에,As aromatic tetracarboxylic dianhydride, a pyromellitic dianhydride etc. are mentioned, respectively, for example,

특허문헌 14(일본공개특허공보 2010-97188호)에 기재된 테트라카본산 2무수물를 이용할 수 있다. The tetracarboxylic dianhydride described in patent document 14 (Unexamined-Japanese-Patent No. 2010-97188) can be used.

상기 그 외의 테트라카본산 2무수물로서는, 1,2,3,4-사이클로부탄테트라카본산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물, 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 3-옥사바이사이클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라하이드로푸란-2',5'-디온), 5-(2,5-디옥소테트라하이드로-3-푸라닐)-3-메틸-3-사이클로헥센-1,2-디카본산 무수물, 3,5,6-트리카복시-2-카복시메틸노르보르난-2:3,5:6-2무수물, 2,4,6,8-테트라카복시바이사이클로[3.3.0]옥탄-2:4,6:8-2무수물 및 4,9-디옥사트리사이클로[5.3.1.02,6]운데칸-3,5,8,10-테트라온으로 이루어지는 군으로부터 선택되는 적어도 1종(이하, 「특정 테트라카본산 2무수물」이라고 함)을 포함하는 것이 바람직하다. As said other tetracarboxylic dianhydride, 1,2,3,4-cyclobutane tetracarboxylic dianhydride, 2,3,5- tricarboxy cyclopentyl acetic dianhydride, 1,3,3a, 4,5, 9b-hexahydro-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 1,3,3a, 4,5 , 9b-hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 3-oxabi Cyclo [3.2.1] octane-2,4-dione-6-spiro-3 '-(tetrahydrofuran-2', 5'-dione), 5- (2,5-dioxotetrahydro-3-fura Yl) -3-methyl-3-cyclohexene-1,2-dicarboxylic acid anhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornane-2: 3,5: 6-2 anhydride, 2, 4,6,8-tetracarboxybicyclo [3.3.0] octane-2: 4,6: 8-2 anhydride and 4,9-dioxatricyclo [5.3.1.0 2,6 ] undecane-3,5 At least one selected from the group consisting of, 8,10-tetraone (hereinafter, "specific tetracarboxylic dianhydride" To include yelling) is preferred.

상기 특정 테트라카본산 2무수물의 사용 비율은, 상기 그 외의 테트라카본산 2무수물 전체에 대하여, 50몰% 이상인 것이 바람직하고, 80몰% 이상인 것이 보다 바람직하고, 100몰%인 것이 특히 바람직하다. It is preferable that it is 50 mol% or more with respect to the whole said other tetracarboxylic dianhydride, it is more preferable that it is 80 mol% or more, and, as for the use ratio of the said specific tetracarboxylic dianhydride, it is especially preferable that it is 100 mol%.

<디아민> <Diamine>

본 발명에 있어서의 폴리암산을 합성하기 위해 이용되는 디아민으로서는, 예를 들면 지방족 디아민, 지환식 디아민, 방향족 디아민, 디아미노오르가노실록산 등을 들 수 있다. 이들의 구체예로서는, 지방족 디아민으로서, 예를 들면 1,1-메타자일릴렌디아민, 1,3-프로판디아민, 테트라메틸렌디아민, 펜타메틸렌디아민, 헥사메틸렌디아민 등을; As a diamine used for synthesize | combining the polyamic acid in this invention, aliphatic diamine, alicyclic diamine, aromatic diamine, diamino organosiloxane, etc. are mentioned, for example. As these specific examples, As an aliphatic diamine, For example, 1, 1- metha xylylenediamine, 1, 3- propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, etc .;

지환식 디아민으로서, 예를 들면 1,4-디아미노사이클로헥산, 4,4'-메틸렌비스(사이클로헥실아민), 1,3-비스(아미노메틸)사이클로헥산 등을; As alicyclic diamine, For example, 1, 4- diamino cyclohexane, 4, 4'- methylenebis (cyclohexylamine), 1, 3-bis (aminomethyl) cyclohexane, etc .;

방향족 디아민으로서, 예를 들면 p-페닐렌디아민, 4,4'-디아미노디페닐메탄, 4,4'-디아미노디페닐술피드, 4,4'-디아미노디페닐아민, 1,5-디아미노나프탈렌, 2,2'-디메틸-4,4'-디아미노비페닐, 4,4'-디아미노-2,2'-비스(트리플루오로메틸)비 페닐, 2,7-디아미노플루오렌, 4,4'-디아미노디페닐에테르, 2,2-비스[4-(4-아미노페녹시)페닐]프로판, 9,9-비스(4-아미노페닐)플루오렌, 2,2-비스[4-(4-아미노페녹시) 페닐]헥사플루오로프로판, 2,2-비스(4-아미노페닐)헥사플루오로프로판, 4,4'-(p-페닐렌디이소프로필리덴)비스아닐린, 4,4'-(m-페닐렌디이소프로필리덴)비스아닐린, 1,4-비스(4-아미노페녹시)벤젠, 4,4'-비스(4-아미노페녹시)비페닐, 2,6-디아미노피리딘, 3,4-디아미노피리딘, 2,4-디아미노피리미딘, 3,6-디아미노아크리딘, 3,6-디아미노카르바졸, N-메틸-3,6-디아미노카르바졸, N-에틸-3,6-디아미노카르바졸, N-페닐-3,6-디아미노카르바졸, N,N'-비스(4-아미노페닐)-벤지딘, N,N'-비스(4-아미노페닐)-N,N'-디메틸벤지딘, 1,4-비스-(4-아미노페닐)-피페라진, 3,5-디아미노벤조산, 콜레스타닐옥시-3,5-디아미노벤젠, 콜레스테닐옥시-3,5-디아미노벤젠, 콜레스타닐옥시-2,4-디아미노벤젠, 콜레스테닐옥시-2,4-디아미노벤젠, 3,5-디아미노벤조산 콜레스타닐, 3,5-디아미노벤조산 콜레스테닐, 3,5-디아미노벤조산 라노스타닐, 3,6-비스(4-아미노벤조일옥시)콜레스탄, 3,6-비스(4-아미노페녹시)콜레스탄, 4-(4'-트리플루오로메톡시벤조일옥시)사이클로헥실-3,5-디아미노벤조에이트, 4-(4'-트리플루오로메틸벤조일옥시)사이클로헥실-3,5-디아미노벤조에이트, 1,1-비스(4-((아미노페닐)메틸)페닐)-4-부틸사이클로헥산, 1,1-비스(4-((아미노페닐)메틸)페닐)-4-헵틸사이클로헥산, 1,1-비스(4-((아미노페녹시)메틸)페닐)-4-헵틸사이클로헥산, 1,1-비스(4-((아미노페닐)메틸)페닐)-4-(4-헵틸사이클로헥실)사이클로헥산 및 하기식 (A-1):As aromatic diamine, for example, p-phenylenediamine, 4,4'- diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfide, 4,4'- diaminodiphenylamine, 1,5 -Diaminonaphthalene, 2,2'-dimethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, 2,7-dia Minofluorene, 4,4'-diaminodiphenylether, 2,2-bis [4- (4-aminophenoxy) phenyl] propane, 9,9-bis (4-aminophenyl) fluorene, 2, 2-bis [4- (4-aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-aminophenyl) hexafluoropropane, 4,4 '-(p-phenylenediisopropylidene) Bisaniline, 4,4 '-(m-phenylenediisopropylidene) bisaniline, 1,4-bis (4-aminophenoxy) benzene, 4,4'-bis (4-aminophenoxy) biphenyl, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine, 3,6-diaminocarbazole, N-methyl-3,6 Diaminocarbazole, N-ethyl-3, 6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, N, N'-bis (4-aminophenyl) -benzidine, N, N'-bis (4-aminophenyl) -N, N'-dimethylbenzidine, 1,4-bis- (4-aminophenyl) -piperazine, 3,5-diaminobenzoic acid, cholestanyloxy-3,5-diaminobenzene, cholestenyloxy-3, 5-diaminobenzene, cholestanyloxy-2,4-diaminobenzene, cholestenyloxy-2,4-diaminobenzene, 3,5-diaminobenzoic acid cholestanyl, 3,5-diaminobenzoic acid Cholestenyl, 3,5-diaminobenzoic acid ranostanyl, 3,6-bis (4-aminobenzoyloxy) cholestane, 3,6-bis (4-aminophenoxy) cholestane, 4- (4 ' -Trifluoromethoxybenzoyloxy) cyclohexyl-3,5-diaminobenzoate, 4- (4'-trifluoromethylbenzoyloxy) cyclohexyl-3,5-diaminobenzoate, 1,1-bis (4-((aminophenyl) methyl) phenyl) -4-butylcyclohexane, 1,1-bis (4-((aminophenyl) methyl) phenyl) -4-heptylcyclohexane, 1,1- S (4-((aminophenoxy) methyl) phenyl) -4-heptylcyclohexane, 1,1-bis (4-((aminophenyl) methyl) phenyl) -4- (4-heptylcyclohexyl) cyclohexane And the following formula (A-1):

Figure pat00001
Figure pat00001

(식 (A-1) 중, XI은 탄소수 1∼3의 알킬렌기, *-O-, *-COO- 또는 *-OCO-(단, 「*」을 붙인 결합손이 디아미노페닐기와 결합함)이고, a는 0 또는 1이고, b는 0∼2의 정수이고, c는 1∼20의 정수임) (In formula (A-1), X <I> is a C1-C3 alkylene group, * -O-, * -COO-, or * -OCO- (However, the bond which attached "*" couples with a diaminophenyl group.) A is 0 or 1, b is an integer of 0 to 2, c is an integer of 1 to 20)

로 나타나는 화합물 등을; Compounds represented by these;

디아미노오르가노실록산으로서, 예를 들면 1,3-비스(3-아미노프로필)-테트라메틸디실록산 등을 각각 들 수 있는 것 외에,Examples of the diaminoorganosiloxanes include 1,3-bis (3-aminopropyl) -tetramethyldisiloxane and the like.

특허문헌 14(일본공개특허공보 2010-97188호)에 기재된 디아민을 이용할 수 있다. The diamine described in patent document 14 (Unexamined-Japanese-Patent No. 2010-97188) can be used.

상기식 (A-1)에 있어서의 XI은 탄소수 1∼3의 알킬렌기, *-O- 또는 *-COO-(단, 「*」을 붙인 결합손이 디아미노페닐기와 결합함)인 것이 바람직하다. 기 CcH2c+1-의 구체예로서는, 예를 들면 메틸기, 에틸기, n-프로필기, n-부틸기, n-펜틸기, n-헥실기, n-헵틸기, n-옥틸기, n-노닐기, n-데실기, n-도데실기, n-트리데실기, n-테트라데실기, n-펜타데실기, n-헥사데실기, n-헵타데실기, n-옥타데실기, n-노나데실기, n-에이코실기 등을 들 수 있다. 디아미노페닐기에 있어서의 2개의 아미노기는, 다른 기에 대하여 2,4-위치 또는 3,5-위치에 있는 것이 바람직하다. X I in the formula (A-1) is an alkylene group having 1 to 3 carbon atoms, * -O- or * -COO-, provided that the bond to which "*" is attached is combined with a diaminophenyl group. desirable. Group C c H 2c + 1 - Specific examples of, for example, methyl, ethyl, n- propyl, n- butyl, n- pentyl, n- hexyl, n- heptyl, n- octyl, n -Nonyl group, n-decyl group, n-dodecyl group, n-tridecyl group, n-tetradecyl group, n-pentadecyl group, n-hexadecyl group, n-heptadecyl group, n-octadecyl group, n-nonadecyl group, n-eicosyl group, etc. are mentioned. It is preferable that two amino groups in a diaminophenyl group exist in 2, 4-position or 3, 5-position with respect to another group.

상기식 (A-1)로 나타나는 화합물의 구체예로서는, 예를 들면 도데칸옥시-2,4-디아미노벤젠, 테트라데칸옥시-2,4-디아미노벤젠, 펜타데칸옥시-2,4-디아미노벤젠, 헥사데칸옥시-2,4-디아미노벤젠, 옥타데칸옥시-2,4-디아미노벤젠, 도데칸옥시-2,5-디아미노벤젠, 테트라데칸옥시-2,5-디아미노벤젠, 펜타데칸옥시-2,5-디아미노벤젠, 헥사데칸옥시-2,5-디아미노벤젠, 옥타데칸옥시-2,5-디아미노벤젠, 하기식 (A-1-1)∼(A-1-3):As a specific example of a compound represented by said formula (A-1), For example, dodecaneoxy-2,4-diaminobenzene, tetradecaneoxy-2,4-diaminobenzene, pentadecaneoxy-2,4-dia Minobenzene, hexadecaneoxy-2,4-diaminobenzene, octadecaneoxy-2,4-diaminobenzene, dodecaneoxy-2,5-diaminobenzene, tetradecaneoxy-2,5-diaminobenzene Pentadecaneoxy-2,5-diaminobenzene, hexadecaneoxy-2,5-diaminobenzene, octadecaneoxy-2,5-diaminobenzene, the following formulas (A-1-1) to (A- 1-3):

Figure pat00002
Figure pat00002

의 각각으로 나타나는 화합물 등을 들 수 있다. The compound etc. which are represented by each of these are mentioned.

상기식 (A-1)에 있어서, a 및 b는 동시에는 0이 되지 않는 것이 바람직하다. In Formula (A-1), a and b are preferably not 0 at the same time.

상기 디아민은, p-페닐렌디아민, 3,5-디아미노벤조산, 4,4'-디아미노디페닐에테르, 4,4'-디아미노디페닐메탄, 2,2'-디메틸-4,4'-디아미노비페닐, 4,4'-디아미노-2,2'-비스(트리플루오로메틸)비페닐, 4,4'-디아미노디페닐아민 및 4,4'-(m-페닐렌디이소프로필리덴)디아닐린으로 이루어지는 군으로부터 선택되는 적어도 1종(이하, 「특정 디아민 1」이라고 함)을 포함하는 것이 바람직하다. The diamine is p-phenylenediamine, 3,5-diaminobenzoic acid, 4,4'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane, 2,2'-dimethyl-4,4 '-Diaminobiphenyl, 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, 4,4'-diaminodiphenylamine and 4,4'-(m-phenyl It is preferable to contain at least 1 sort (s) hereafter called "specific diamine 1" chosen from the group which consists of a lendiisopropylidene) dianiline.

또한, 본 발명의 액정 배향제가 수직 배향형(VA형)의 액정 표시 소자에 있어서의 액정 배향막의 형성에 이용되는 것인 경우에는, 상기와 같은 특정 디아민 외에, 콜레스타닐옥시-3,5-디아미노벤젠, 콜레스테닐옥시-3,5-디아미노벤젠, 콜레스타닐옥시-2,4-디아미노벤젠, 콜레스테닐옥시-2,4-디아미노벤젠, 3,5-디아미노벤조산 콜레스타닐, 3,5-디아미노벤조산 콜레스테닐, 3,5-디아미노벤조산 라노스타닐, 3,6-비스(4-아미노벤조일옥시)콜레스탄, 3,6-비스(4-아미노페녹시)콜레스탄 및 상기식 (A-1)로 나타나는 화합물로 이루어지는 군으로부터 선택되는 적어도 1종(이하, 「특정 디아민 2」라고 함)을 추가로 포함하는 것이 바람직하다. In addition, when the liquid crystal aligning agent of this invention is used for formation of the liquid crystal aligning film in the liquid crystal display element of a vertical alignment type (VA type), in addition to the above-mentioned specific diamine, cholestanyloxy-3,5- Diaminobenzene, cholestenyloxy-3,5-diaminobenzene, cholestanyloxy-2,4-diaminobenzene, cholestenyloxy-2,4-diaminobenzene, 3,5-diaminobenzoic acid Cholestanyl, 3,5-diaminobenzoic acid cholestenyl, 3,5-diaminobenzoic acid ranostanyl, 3,6-bis (4-aminobenzoyloxy) cholestane, 3,6-bis (4-amino It is preferable to further contain at least 1 type (henceforth "specific diamine 2") chosen from the group which consists of a phenoxy) cholestan and the compound represented by said formula (A-1).

본 발명의 액정 배향제가 VA형의 수직 배향형의 액정 표시 소자에 있어서의 액정 배향막의 형성에 이용되는 것인 경우, 상기 특정 디아민 1 및 특정 디아민 2의 전체 디아민에 대한 바람직한 사용 비율은 하기한 바와 같다. When the liquid crystal aligning agent of this invention is used for formation of the liquid crystal aligning film in VA type | mold vertical alignment type liquid crystal display element, the preferable use ratio with respect to all the diamine of the said specific diamine 1 and the specific diamine 2 is as follows. same.

특정 디아민 1: 바람직하게는 20∼97%, 보다 바람직하게는 50∼95%, 특히 바람직하게는 60∼90% Specific diamine 1: Preferably it is 20 to 97%, More preferably, it is 50 to 95%, Especially preferably, it is 60 to 90%

특정 디아민 2: 바람직하게는 3∼80몰%, 보다 바람직하게는 5∼50%, 특히 바람직하게는 10∼40% Specific diamine 2: Preferably it is 3 to 80 mol%, More preferably, it is 5 to 50%, Especially preferably, it is 10 to 40%

이 경우, 상기 특정 디아민 1 및 특정 디아민 2의 합계의 사용 비율을, 전체 디아민에 대하여 100몰%로 하는 것이 바람직하다. In this case, it is preferable to make the use ratio of the sum total of the said specific diamine 1 and the specific diamine 2 into 100 mol% with respect to all diamine.

한편, 본 발명의 액정 배향제가 VA형 이외의 액정 표시 소자(예를 들면 TN(Twisted Nematic)형, STN(Super Twisted Nematic)형, 횡전계 방식(예를 들면 IPS(In-Plane Switching), FFS(Fringe Field Switching) 등) 등)에 있어서의 액정 배향막의 형성에 이용되는 것인 경우, 상기 특정 디아민 1 및 특정 디아민 2의 전체 디아민에 대한 바람직한 사용 비율은 하기에 기재한 바와 같다. On the other hand, the liquid crystal aligning agent of this invention is liquid crystal display elements (for example, TN (Twisted Nematic) type, STN (Super Twisted Nematic) type, transverse electric field system (for example, IPS (In-Plane Switching), FFS) other than VA type). (Fringe Field Switching, etc.), etc.), when used for formation of the liquid crystal aligning film, the preferable use ratio with respect to all the diamine of the said specific diamine 1 and the specific diamine 2 is as having described below.

특정 디아민 1: 바람직하게는 50몰% 이상, 보다 바람직하게는 80몰% 이상, 특히 바람직하게는 100몰% Specific diamine 1: Preferably it is 50 mol% or more, More preferably, it is 80 mol% or more, Especially preferably, it is 100 mol%

특정 디아민 2: 바람직하게는 30몰% 이하, 보다 바람직하게는 10% 이하, 특히 바람직하게는 0몰% Specific diamine 2: Preferably it is 30 mol% or less, More preferably, it is 10% or less, Especially preferably, 0 mol%

이 경우, 디아민으로서는, 상기 특정 디아민 1 및 특정 디아민 2의 합계를 100몰%로 하는 것이 바람직하고, 특정 디아민 1만을 사용하는 것이 보다 바람직하다. In this case, as a diamine, it is preferable to make the sum total of the said specific diamine 1 and the specific diamine 2 into 100 mol%, and it is more preferable to use only the specific diamine 1 only.

<분자량 조절제> <Molecular weight regulator>

상기 폴리암산을 합성할 때에, 상기와 같은 테트라카본산 2무수물 및 디아민과 함께, 적당한 분자량 조절제를 이용하여 말단 수식형의 중합체를 합성해도 좋다. 폴리암산을 이러한 말단 수식형의 중합체로 함으로써, 당해 폴리암산 및 이것을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제는, 본 발명의 효과를 손상시키는 일 없이 그 도포성(인쇄성)이 더욱 향상된 것이 된다. When synthesize | combining the said polyamic acid, you may synthesize | combine the terminal-modified polymer with the said tetracarboxylic dianhydride and diamine using a suitable molecular weight modifier. By making polyamic acid into such a terminal-modified polymer, the liquid crystal aligning agent containing at least 1 sort (s) of polymer chosen from the group which consists of the said polyamic acid and polyimide formed by dehydrating and ring-closing this impairs the effect of this invention. The coating property (printability) is further improved without.

상기 분자량 조절제로서는, 예를 들면 산 1무수물, 모노아민 화합물, 모노이소시아네이트 화합물 등을 들 수 있다. 이들의 구체예로서는, 산 1무수물로서는, 예를 들면 무수 말레산, 무수 프탈산, 무수 이타콘산, n-데실숙신산 무수물, n-도데실숙신산 무수물, n-테트라데실숙신산 무수물, n-헥사데실숙신산 무수물 등을; As said molecular weight modifier, an acid monoanhydride, a monoamine compound, a monoisocyanate compound, etc. are mentioned, for example. As these specific examples, as acid monoanhydride, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecylsuccinic anhydride, n-hexadecylsuccinic anhydride My back;

모노아민 화합물로서, 예를 들면 아닐린, 사이클로헥실아민, n-부틸아민, n-펜틸아민, n-헥실아민, n-헵틸아민, n-옥틸아민 등을; As a monoamine compound, For example, aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, etc .;

모노이소시아네이트 화합물로서, 예를 들면 페닐이소시아네이트, 나프틸이소시아네이트 등을 각각 들 수 있다. As a monoisocyanate compound, phenyl isocyanate, naphthyl isocyanate, etc. are mentioned, respectively.

분자량 조절제의 사용 비율은, 사용하는 테트라카본산 2무수물 및 디아민의 합계 100중량부에 대하여, 20중량부 이하로 하는 것이 바람직하고, 10중량부 이하로 하는 것이 보다 바람직하다. It is preferable to set it as 20 weight part or less with respect to a total of 100 weight part of tetracarboxylic dianhydride and diamine to be used, and, as for the usage ratio of a molecular weight modifier, it is more preferable to set it as 10 weight part or less.

<폴리암산의 합성> Synthesis of Polyamic Acid

폴리암산의 합성 반응에 제공되는 테트라카본산 2무수물과 디아민과의 사용 비율은, 디아민의 아미노기 1당량에 대하여, 테트라카본산 2무수물의 산 무수물기가 0.2∼2당량이 되는 비율이 바람직하고, 더욱 바람직하게는 0.3∼1.2당량이 되는 비율이다. The use ratio of tetracarboxylic dianhydride and diamine provided in the polyamic acid synthesis reaction is preferably such that the acid anhydride group of tetracarboxylic dianhydride is 0.2 to 2 equivalents to 1 equivalent of the amino group of the diamine. Preferably it is the ratio used as 0.3-1.2 equivalent.

폴리암산의 합성 반응은, 바람직하게는 유기 용매 중에 있어서, 바람직하게는 -20℃∼150℃, 보다 바람직하게는 0∼100℃에서, 바람직하게는 0.1∼24시간, 보다 바람직하게는 0.5∼12시간 행해진다. Synthesis reaction of polyamic acid, Preferably in an organic solvent, Preferably it is -20 degreeC-150 degreeC, More preferably, it is 0-100 degreeC, Preferably it is 0.1-24 hours, More preferably, it is 0.5-12 Time is done.

여기에서, 유기 용매로서는, 예를 들면 비(非)프로톤성 극성 용매, 페놀 및 그 유도체, 알코올, 케톤, 에스테르, 에테르, 할로겐화 탄화 수소, 탄화 수소 등을 들 수 있다. Here, as an organic solvent, a non-protic polar solvent, a phenol, its derivatives, alcohol, a ketone, ester, an ether, halogenated hydrocarbon, hydrocarbon, etc. are mentioned, for example.

이들 유기 용매의 구체예로서는, 상기 비프로톤성 극성 용매로서, 예를 들면 N-메틸-2-피롤리돈, N,N-디메틸아세트아미드, N,N-디메틸포름아미드, 디메틸술폭사이드, γ-부티로락톤, 테트라메틸요소, 헥사메틸포스포르트리아미드 등을; As specific examples of these organic solvents, for example, N-methyl-2-pyrrolidone, N, N-dimethylacetamide, N, N-dimethylformamide, dimethyl sulfoxide, γ- as the aprotic polar solvent. Butyrolactone, tetramethylurea, hexamethylphosphortriamide and the like;

상기 페놀 유도체로서, 예를 들면 m-크레졸, 자일레놀, 할로겐화 페놀 등을; As said phenol derivative, For example, m-cresol, xylenol, a halogenated phenol etc .;

상기 알코올로서, 예를 들면 메틸알코올, 에틸알코올, 이소프로필알코올, 사이클로헥산올, 에틸렌글리콜, 프로필렌글리콜, 1,4-부탄디올, 트리에틸렌글리콜, 에틸렌글리콜모노메틸에테르 등을; As said alcohol, For example, methyl alcohol, ethyl alcohol, isopropyl alcohol, cyclohexanol, ethylene glycol, propylene glycol, 1, 4- butanediol, triethylene glycol, ethylene glycol monomethyl ether, etc .;

상기 케톤으로서, 예를 들면 아세톤, 메틸에틸케톤, 메틸이소부틸케톤, 사이클로헥사논 등을; As said ketone, For example, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc .;

상기 에스테르로서, 예를 들면 락트산 에틸, 락트산 부틸, 아세트산 메틸, 아세트산 에틸, 아세트산 부틸, 메틸메톡시프로피오네이트, 에틸에톡시프로피오네이트, 옥살산 디에틸, 말론산 디에틸 등을; As said ester, For example, ethyl lactate, butyl lactate, methyl acetate, ethyl acetate, butyl acetate, methyl methoxy propionate, ethyl ethoxy propionate, diethyl oxalate, diethyl malonate, etc .;

상기 에테르로서, 예를 들면 디에틸에테르, 에틸렌글리콜메틸에테르, 에틸렌글리콜에틸에테르, 에틸렌글리콜-n-프로필에테르, 에틸렌글리콜-i-프로필에테르, 에틸렌글리콜-n-부틸에테르, 에틸렌글리콜디메틸에테르, 에틸렌글리콜에틸에테르아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트, 테트라하이드로푸란 등을; Examples of the ether include diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol-n-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol-n-butyl ether, ethylene glycol dimethyl ether, Ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetra Hydrofuran and the like;

상기 할로겐화 탄화 수소로서, 예를 들면 디클로로메탄, 1,2-디클로로에탄, 1,4-디클로로부탄, 트리클로로에탄, 클로로벤젠, o-디클로로벤젠 등을; Examples of the halogenated hydrocarbons include dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, and the like;

상기 탄화 수소로서, 예를 들면 헥산, 헵탄, 옥탄, 벤젠, 톨루엔, 자일렌, 이소아밀프로피오네이트, 이소아밀이소부틸레이트, 디이소펜틸에테르 등을 각각 들 수 있다. Examples of the hydrocarbons include hexane, heptane, octane, benzene, toluene, xylene, isoamylpropionate, isoamyl isobutylate, diisopentyl ether, and the like.

이들 유기 용매 중, 비프로톤성 극성 용매 그리고 페놀 및 그 유도체로 이루어지는 군(제1군의 유기 용매)으로부터 선택되는 1종 이상, 또는 상기 제1군의 유기 용매로부터 선택되는 1종 이상과 알코올, 케톤, 에스테르, 에테르, 할로겐화 탄화 수소 및 탄화 수소로 이루어지는 군(제2군의 유기 용매)으로부터 선택되는 1종 이상과의 혼합물을 사용하는 것이 바람직하다. 후자의 경우, 제2군의 유기 용매의 사용 비율은, 제1군의 유기 용매 및 제2군의 유기 용매의 합계에 대하여, 바람직하게는 50중량% 이하이고, 보다 바람직하게는 40중량% 이하이고, 더욱이 30중량% 이하인 것이 바람직하다. Among these organic solvents, at least one selected from the group consisting of aprotic polar solvents and phenols and derivatives thereof (first group of organic solvents), or at least one type and alcohols selected from the first group of organic solvents, Preference is given to using mixtures with at least one member selected from the group consisting of ketones, esters, ethers, halogenated hydrocarbons and hydrocarbons (organic solvents of the second group). In the latter case, the use ratio of the second group of organic solvents is preferably 50% by weight or less, and more preferably 40% by weight or less with respect to the sum of the organic solvents of the first group and the organic solvents of the second group. Furthermore, it is preferable that it is 30 weight% or less.

유기 용매의 사용량(a)은, 테트라카본산 2무수물 및 디아민의 합계량(b)이, 반응 용액의 전체량(a+b)에 대하여 0.1∼50중량%가 되도록 하는 양으로 하는 것이 바람직하다. The amount (a) of the organic solvent is preferably set to an amount such that the total amount (b) of the tetracarboxylic dianhydride and the diamine is 0.1 to 50% by weight relative to the total amount (a + b) of the reaction solution.

이상과 같이 하여, 폴리암산을 용해하여 이루어지는 반응 용액이 얻어진다.As described above, a reaction solution obtained by dissolving polyamic acid is obtained.

이 반응 용액은 그대로 액정 배향제의 조제에 제공해도 좋고, 반응 용액 중에 포함되는 폴리암산을 단리한 후에 액정 배향제의 조제에 제공해도 좋고, 또는 단리한 폴리암산을 정제한 후에 액정 배향제의 조제에 제공해도 좋다. 폴리암산을 탈수 폐환하여 폴리이미드로 하는 경우에는, 상기 반응 용액을 그대로 탈수 폐환 반응에 제공해도 좋고, 반응 용액 중에 포함되는 폴리암산을 단리한 후에 탈수 폐환 반응에 제공해도 좋고, 또는 단리한 폴리암산을 정제한 후에 탈수 폐환 반응에 제공해도 좋다. 폴리암산의 단리 및 정제는 공지의 방법에 따라 행할 수 있다. This reaction solution may be used as it is for preparation of a liquid crystal aligning agent, may be provided to preparation of a liquid crystal aligning agent after isolating the polyamic acid contained in a reaction solution, or after refine | purifying the isolated polyamic acid, preparation of a liquid crystal aligning agent You may provide to. When polyamic acid is dehydrated and closed, and it is set as polyimide, the said reaction solution may be used for a dehydration ring-closure reaction as it is, may be used for dehydration ring-closure reaction after isolating the polyamic acid contained in the reaction solution, or the isolated polyamic acid After purification, the dehydration ring-closure reaction may be used. Isolation and purification of polyamic acid can be performed according to a well-known method.

<폴리이미드의 합성> Synthesis of Polyimide

상기 폴리이미드는, 상기와 같이 하여 합성된 폴리암산을 탈수 폐환하여 이미드화함으로써 얻을 수 있다. The said polyimide can be obtained by dehydrating and ring-closing the polyamic acid synthesize | combined as mentioned above and imidating.

본 발명에 있어서의 폴리이미드는, 그 전구체인 폴리암산이 갖고 있던 암산 구조 모두를 탈수 폐환한 완전 이미드화물이라도 좋고, 암산 구조의 일부만을 탈수 폐환하여, 암산 구조와 이미드환 구조가 병존하는 부분 이미드화물이라도 좋다. 본 발명에 있어서의 폴리이미드는, 그 이미드화율이 30% 이상인 것이 바람직하고, 50% 이상인 것이 보다 바람직하고, 특히 55% 이상인 것이 바람직하다. 이 이미드화율은, 폴리이미드의 암산 구조의 수와 이미드환 구조의 수와의 합계에 대한 이미드환 구조의 수가 차지하는 비율을 백분율로 나타낸 것이다. 여기에서, 이미드환의 일부가 이소이미드환이라도 좋다. The polyimide in the present invention may be a complete imide obtained by dehydrating and ring-closing all the dark acid structures possessed by the polyamic acid as a precursor thereof, or by dehydrating and ring-closing only a part of the dark acid structure to coexist with the dark acid structure and the imide ring structure. Imide may be sufficient. It is preferable that the imidation ratio of the polyimide in this invention is 30% or more, It is more preferable that it is 50% or more, It is preferable that it is especially 55% or more. This imidation ratio shows the ratio which the number of the imide ring structure to the sum of the number of the dark acid structures of a polyimide, and the number of imide ring structures occupies as a percentage. Here, part of the imide ring may be an isoimide ring.

폴리암산의 탈수 폐환은, 바람직하게는 폴리암산을 가열하는 방법에 의해, 또는 폴리암산을 유기 용매에 용해하고, 이 용액 중에 탈수제 및 탈수 폐환 촉매를 첨가하여 필요에 따라서 가열하는 방법에 의해 행해진다. 이 중, 후자의 방법에 의한 것이 바람직하다. The dehydration ring closure of the polyamic acid is preferably carried out by a method of heating the polyamic acid, or by dissolving the polyamic acid in an organic solvent, adding a dehydrating agent and a dehydration ring closure catalyst to the solution and heating it as necessary. . Among these, it is preferable by the latter method.

상기 폴리암산의 용액 중에 탈수제 및 탈수 폐환 촉매를 첨가하는 방법에 있어서, 탈수제로서는, 예를 들면 무수 아세트산, 무수 프로피온산, 무수 트리플루오로아세트산 등의 산 무수물을 이용할 수 있다. 탈수제의 사용량은, 폴리암산의 암산 구조 1몰에 대하여 0.01∼20몰로 하는 것이 바람직하다. 탈수 폐환 촉매로서는, 예를 들면 피리딘, 콜리딘, 루티딘, 트리에틸아민 등의 3급 아민을 이용할 수 있다. 탈수 폐환 촉매의 사용량은, 사용하는 탈수제 1몰에 대하여 0.01∼10몰로 하는 것이 바람직하다. 탈수 폐환 반응에 이용되는 유기 용매로서는, 폴리암산의 합성에 이용되는 것으로서 예시한 유기 용매를 들 수 있다. 탈수 폐환 반응의 반응 온도는 바람직하게는 0∼180℃이고, 보다 바람직하게는 10∼150℃이다. 반응 시간은 바람직하게는 1.0∼120시간이고, 보다 바람직하게는 2.0∼30시간이다. In the method of adding a dehydrating agent and a dehydrating ring-closure catalyst in the solution of the polyamic acid, for example, acid anhydrides such as acetic anhydride, propionic anhydride and trifluoroacetic anhydride can be used as the dehydrating agent. It is preferable that the usage-amount of a dehydrating agent shall be 0.01-20 mol with respect to 1 mol of dark acid structures of polyamic acid. As the dehydration ring closure catalyst, tertiary amines such as pyridine, collidine, lutidine and triethylamine can be used, for example. It is preferable that the usage-amount of a dehydration ring-closure catalyst shall be 0.01-10 mol with respect to 1 mol of dehydrating agents used. As an organic solvent used for a dehydration ring-closure reaction, the organic solvent illustrated as what is used for the synthesis | combination of a polyamic acid is mentioned. The reaction temperature of the dehydration ring-closure reaction is preferably 0 to 180 ° C, more preferably 10 to 150 ° C. The reaction time is preferably 1.0 to 120 hours, more preferably 2.0 to 30 hours.

이와 같이 하여 폴리이미드를 함유하는 반응 용액이 얻어진다. 이 반응 용액은, 이것을 그대로 액정 배향제의 조제에 제공해도 좋고, 반응 용액으로부터 탈수제 및 탈수 폐환 촉매를 제거한 후에 액정 배향제의 조제에 제공해도 좋고, 폴리이미드를 단리한 후에 액정 배향제의 조제에 제공해도 좋고, 또는 단리한 폴리이미드를 정제한 후에 액정 배향제의 조제에 제공해도 좋다. 이들 정제 조작은 공지의 방법에 따라 행할 수 있다. In this way, a reaction solution containing a polyimide is obtained. This reaction solution may be provided as it is to preparation of a liquid crystal aligning agent as it is, may be provided to preparation of a liquid crystal aligning agent after removing a dehydrating agent and a dehydration ring-closure catalyst from a reaction solution, and after isolation of a polyimide to preparation of a liquid crystal aligning agent You may provide, or after refine | purifying an isolated polyimide, you may provide for preparation of a liquid crystal aligning agent. These purification operations can be performed according to a well-known method.

<중합체의 용액 점도> <Solution Viscosity of Polymer>

이상과 같이 하여 얻어지는 특정 중합체는, 이것을 농도 10중량%의 용액으로 했을 때에, 20∼800mPa·s의 용액 점도를 갖는 것이 바람직하고, 30∼500mPa·s의 용액 점도를 갖는 것이 보다 바람직하다. When the specific polymer obtained as mentioned above is made into the solution of 10 weight% of concentration, it is preferable to have a solution viscosity of 20-800 mPa * s, and it is more preferable to have a solution viscosity of 30-500 mPa * s.

상기 중합체의 용액 점도(mPa·s)는, 당해 중합체의 양(良)용매(예를 들면 γ-부티로락톤, N-메틸-2-피롤리돈 등)를 이용하여 조제한 농도 10중량%의 중합체 용액에 대해서, E형 회전 점도계를 이용하여 25℃에서 측정한 값이다. The solution viscosity (mPa * s) of the said polymer is 10 weight% of the density | concentration prepared using the quantity solvent of the said polymer (for example, (gamma) -butyrolactone, N-methyl- 2-pyrrolidone, etc.). About a polymer solution, it is the value measured at 25 degreeC using the E-type rotational viscometer.

<그 외의 첨가제> <Other additives>

본 발명의 액정 배향막은, 상기와 같은 특정 중합체를 필수 성분으로서 함유하지만, 필요에 따라서 그 외의 성분을 함유하고 있어도 좋다. 이러한 그 외의 성분으로서는, 예를 들면 상기 특정 중합체 이외의 중합체(이하, 「기타 중합체」라고 함), 분자 내에 적어도 1개의 에폭시기를 갖는 화합물(이하, 「에폭시 화합물」이라고 함), 관능성 실란 화합물 등을 들 수 있다. Although the liquid crystal aligning film of this invention contains the above-mentioned specific polymer as an essential component, you may contain other components as needed. As such other components, polymers other than the said specific polymer (henceforth "other polymer"), the compound which has at least 1 epoxy group in a molecule (henceforth "epoxy compound"), a functional silane compound Etc. can be mentioned.

[기타 중합체][Other polymers]

상기 기타 중합체는, 용액 특성 및 전기 특성의 개선을 위해 사용할 수 있다. 이러한 기타 중합체는, 특정 중합체 이외의 중합체이며, 예를 들면 테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산으로서, 전체 테트라카본산 2무수물에 대한 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종의 함유 비율이 5몰% 미만이거나, 혹은 80몰%를 초과하는, 상기 폴리암산(이하, 「기타 폴리암산」이라고 함), 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드(이하,「기타 폴리이미드」라고 함), 폴리암산 에스테르, 폴리에스테르, 폴리아미드, 폴리실록산, 셀룰로오스 유도체, 폴리아세탈, 폴리스티렌 유도체, 폴리(스티렌-페닐말레이미드) 유도체, 폴리(메타)아크릴레이트 등을 들 수 있다. 이들 중, 기타 폴리암산 또는 기타 폴리이미드가 바람직하고, 기타 폴리암산이 보다 바람직하다. The other polymer can be used for improving solution properties and electrical properties. Such other polymers are polymers other than the specific polymer, and are, for example, polyamic acid obtained by reacting tetracarboxylic dianhydride and diamine, and are 1S, 2S, 4R, 5R-cyclohexanetetracarbonate with respect to all tetracarboxylic dianhydrides. The polyamic acid having a content ratio of at least one selected from the group consisting of acid dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride is less than 5 mol% or more than 80 mol% ( Hereinafter, "other polyamic acid"), polyimide formed by dehydrating and closing the polyamic acid (hereinafter referred to as "other polyimide"), polyamic acid ester, polyester, polyamide, polysiloxane, cellulose derivative, polyacetal , Polystyrene derivatives, poly (styrene-phenylmaleimide) derivatives, poly (meth) acrylates and the like. Among these, other polyamic acid or other polyimide is preferable, and other polyamic acid is more preferable.

상기 기타 폴리암산 또는 기타 폴리이미드를 합성하기 위해 이용되는 테트라카본산 2무수물로서는, 특정 중합체를 합성하기 위해 바람직하게 사용되는 그 외의 테트라카본산 2무수물로서 전술한 것과 동일한 것을 들 수 있지만, 바람직하게는 1,2,3,4-사이클로부탄테트라카본산 2무수물, 피로멜리트산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 및 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온으로 이루어지는 군으로부터 선택되는 적어도 1종을 사용하는 것이 바람직하다. As tetracarboxylic dianhydride used for synthesizing the said other polyamic acid or other polyimide, although the thing similar to what was mentioned above as other tetracarboxylic dianhydride preferably used for synthesize | combining a specific polymer is mentioned preferably, Is 1,2,3,4-cyclobutanetetracarboxylic dianhydride, pyromellitic dianhydride, 2,3,5-tricarboxycyclopentyl acetic dianhydride and 1,3,3a, 4,5,9b-hexa It is preferable to use at least one member selected from the group consisting of hydro-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione. desirable.

상기 기타 폴리암산 또는 기타 폴리이미드를 합성하기 위해 이용되는 디아민으로서는, 특정 중합체를 합성할 때에 이용되는 디아민으로서 상기에 예시한 것 중으로부터 선택되는 적어도 1종을 사용하는 것이 바람직하다. 기타 폴리암산 또는 기타 폴리이미드를 합성하기 위해 이용되는 디아민으로서는, 4,4'-디아미노디페닐메탄, 2,2'-디메틸-4,4'-디아미노비페닐, 콜레스타닐옥시-2,4-디아미노벤젠, 3,5-디아미노벤조산 및 1,4-비스-(4-아미노페닐)-피페라진으로 이루어지는 군으로부터 선택되는 적어도 1종을 사용하는 것이 바람직하다. As the diamine used to synthesize the other polyamic acid or other polyimide, it is preferable to use at least one selected from those exemplified above as the diamine used when synthesizing the specific polymer. Examples of the diamine used to synthesize other polyamic acid or other polyimide include 4,4'-diaminodiphenylmethane, 2,2'-dimethyl-4,4'-diaminobiphenyl and cholestanyloxy-2. Preference is given to using at least one member selected from the group consisting of, 4-diaminobenzene, 3,5-diaminobenzoic acid and 1,4-bis- (4-aminophenyl) -piperazine.

기타 중합체의 사용 비율로서는, 중합체의 합계(상기의 특정 중합체 및 기타 중합체의 합계를 말함, 이하 동일)에 대하여 바람직하게는 50중량% 이하이고, 보다 바람직하게는 40중량% 이하이고, 더욱이 30중량% 이하인 것이 바람직하다. 기타 중합체를 사용하는 경우, 그 사용 비율을 중합체의 합계에 대하여 0.1중량% 이상으로 하면, 그 첨가의 효과가 의미 있게 발현된다. As a usage ratio of other polymer, it is 50 weight% or less, More preferably, it is 40 weight% or less with respect to the sum total of a polymer (it says the sum total of said specific polymer and other polymers, the same hereafter), and further 30 weights It is preferable that it is% or less. When using other polymer, when the use ratio is 0.1 weight% or more with respect to the sum total of a polymer, the effect of the addition will express significantly.

[에폭시 화합물] [Epoxy Compound]

에폭시 화합물은, 얻어지는 액정 배향막의 기판에 대한 접착성 및 내열성 등을 더욱 향상하는 목적에서, 본 발명의 액정 배향제에 함유될 수 있다. An epoxy compound can be contained in the liquid crystal aligning agent of this invention for the purpose of further improving adhesiveness, heat resistance, etc. with respect to the board | substrate of the liquid crystal aligning film obtained.

상기 에폭시 화합물로서는, 분자 내에 2개 이상의 에폭시기를 갖는 에폭시 화합물이 바람직하며, 예를 들면 에틸렌글리콜디글리시딜에테르, 폴리에틸렌글리콜디글리시딜에테르, 프로필렌글리콜디글리시딜에테르, 트리프로필렌글리콜디글리시딜에테르, 폴리프로필렌글리콜디글리시딜에테르, 네오펜틸글리콜디글리시딜에테르, 1,6-헥산디올디글리시딜에테르, 글리세린디글리시딜에테르, 트리메틸올프로판트리글리시딜에테르, 2,2-디브로모네오펜틸글리콜디글리시딜에테르, N,N,N',N'-테트라글리시딜-m-자일렌디아민, 1,3-비스(N,N-디글리시딜아미노메틸)사이클로헥산, N,N,N',N'-테트라글리시딜-4,4'-디아미노디페닐메탄, N,N-디글리시딜-벤질아민, N,N-디글리시딜-아미노메틸사이클로헥산, N,N-디글리시딜-사이클로헥실아민 등을 바람직한 것으로서 들 수 있다. As said epoxy compound, the epoxy compound which has two or more epoxy groups in a molecule | numerator is preferable, For example, ethylene glycol diglycidyl ether, polyethyleneglycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol di Glycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerin diglycidyl ether, trimethylol propane triglycidyl ether, 2,2-dibromoneopentylglycol diglycidyl ether, N, N, N ', N'-tetraglycidyl-m-xylenediamine, 1,3-bis (N, N-diglycid) Dilaminomethyl) cyclohexane, N, N, N ', N'-tetraglycidyl-4,4'-diaminodiphenylmethane, N, N-diglycidyl-benzylamine, N, N-di Glycidyl-aminomethylcyclohexane, N, N- diglycidyl cyclohexylamine, etc. are mentioned as a preferable thing. .

에폭시 화합물은, 그 사용 비율이 과소하면 상기와 같은 소기의 효과가 충분히 발현되지 않고, 한편 사용 비율이 과대하면 액정 배향막의 리워크성 및 러빙 내성이 손상된다. 이러한 관점에서 에폭시 화합물의 배합 비율은, 중합체의 합계 100중량부에 대하여, 30중량부 이하로 하는 것이 바람직하고, 0.1∼15중량부로 하는 것이 보다 바람직하고, 바람직하게는 0.5∼8중량부로 하는 것이 더욱 바람직하고, 특히 1∼3중량부로 하는 것이 바람직하다. When the use ratio is too small, the desired effect as described above is not sufficiently exhibited. On the other hand, when the use ratio is excessive, the reworkability and rubbing resistance of the liquid crystal alignment film are impaired. From such a viewpoint, the compounding ratio of the epoxy compound is preferably 30 parts by weight or less, more preferably 0.1 to 15 parts by weight, and more preferably 0.5 to 8 parts by weight with respect to 100 parts by weight of the total polymer. More preferably, it is especially preferable to set it as 1-3 weight part.

[관능성 실란 화합물] [Functional silane compound]

상기 관능성 실란 화합물로서는, 예를 들면 3-아미노프로필트리메톡시실란, 3-아미노프로필트리에톡시실란, 2-아미노프로필트리메톡시실란, 2-아미노프로필트리에톡시실란, N-(2-아미노에틸)-3-아미노프로필트리메톡시실란, N-(2-아미노에틸)-3-아미노프로필메틸디메톡시실란, 3-우레이도프로필트리메톡시실란, 3-우레이도프로필트리에톡시실란, N-에톡시카보닐-3-아미노프로필트리메톡시실란, N-에톡시카보닐-3-아미노프로필트리에톡시실란, N-트리에톡시실릴프로필트리에틸렌트리아민, N-트리메톡시실릴프로필트리에틸렌트리아민, 10-트리메톡시실릴-1,4,7-트리아자데칸, 10-트리에톡시실릴-1,4,7-트리아자데칸, 9-트리메톡시실릴-3,6-디아자노닐아세테이트, 9-트리에톡시실릴-3,6-디아자노닐아세테이트, 9-트리메톡시실릴-3,6-디아자노난산 메틸, 9-트리에톡시실릴-3,6-디아자노난산 메틸, N-벤질-3-아미노프로필트리메톡시실란, N-벤질-3-아미노프로필트리에톡시실란, N-페닐-3-아미노프로필트리메톡시실란, N-페닐-3-아미노프로필트리에톡시실란, 글리시독시메틸트리메톡시실란, 글리시독시메틸트리에톡시실란, 2-글리시독시에틸트리메톡시실란, 2-글리시독시에틸트리에톡시실란, 3-글리시독시프로필트리메톡시실란, 3-글리시독시프로필트리에톡시실란 등을 들 수 있다. As said functional silane compound, 3-aminopropyl trimethoxysilane, 3-aminopropyl triethoxysilane, 2-aminopropyl trimethoxysilane, 2-aminopropyl triethoxysilane, N- (2 -Aminoethyl) -3-aminopropyltrimethoxysilane, N- (2-aminoethyl) -3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxy Silane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimeth Methoxysilylpropyltriethylenetriamine, 10-trimethoxysilyl-1,4,7-triazadecan, 10-triethoxysilyl-1,4,7-triazadecan, 9-trimethoxysilyl-3 , 6-Diazonayl acetate, 9-triethoxysilyl-3,6-diazanyl acetate, 9-trimethoxysilyl-3,6-methyl diazanoanoate, 9-triethoxy Methyl 3,6-diazananoic acid, N-benzyl-3-aminopropyltrimethoxysilane, N-benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, glycidoxymethyltrimethoxysilane, glycidoxymethyltriethoxysilane, 2-glycidoxyethyltrimethoxysilane, 2-glycidoxyethyltrie A methoxysilane, 3-glycidoxy propyl trimethoxysilane, 3-glycidoxy propyl triethoxysilane, etc. are mentioned.

이들 관능성 실란 화합물의 배합 비율은, 중합체의 합계 100중량부에 대하여, 바람직하게는 2중량부 이하, 보다 바람직하게는 0.02∼0.2중량부이다. The blending ratio of these functional silane compounds is preferably 2 parts by weight or less, more preferably 0.02 to 0.2 parts by weight based on 100 parts by weight of the polymer in total.

<액정 배향제><Liquid crystal aligning agent>

본 발명의 액정 배향제는, 상기와 같은 특정 중합체 및 필요에 따라서 임의적으로 배합되는 그 외의 첨가제가, 바람직하게는 유기 용매 중에 용해 함유되어 구성된다. The liquid crystal aligning agent of this invention is melt | dissolved and contained in the organic solvent, Preferably the specific polymer mentioned above and other additives mix | blended arbitrarily as needed are comprised.

본 발명의 액정 배향제에 사용되는 유기 용매로서는, 예를 들면 N-메틸-2-피롤리돈, γ-부티로락톤, γ-부티로락탐, N,N-디메틸포름아미드, N,N-디메틸아세트아미드, 4-하이드록시-4-메틸-2-펜타논, 에틸렌글리콜모노메틸에테르, 락트산 부틸, 아세트산 부틸, 메틸메톡시프로피오네이트, 에틸에톡시프로피오네이트, 에틸렌글리콜메틸에테르, 에틸렌글리콜에틸에테르, 에틸렌글리콜-n-프로필에테르, 에틸렌글리콜-i-프로필에테르, 에틸렌글리콜-n-부틸에테르(부틸셀로솔브), 에틸렌글리콜디메틸에테르, 에틸렌글리콜에틸에테르아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트, 디이소부틸케톤, 이소아밀프로피오네이트, 이소아밀이소부틸레이트, 디이소펜틸에테르, 에틸렌카보네이트, 프로필렌카보네이트 등을 들 수 있다. 이들은 단독으로 사용할 수 있고, 또는 2종 이상을 혼합하여 사용할 수 있다. As an organic solvent used for the liquid crystal aligning agent of this invention, N-methyl- 2-pyrrolidone, (gamma) -butyrolactone, (gamma) -butyrolactam, N, N- dimethylformamide, N, N- Dimethylacetamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxy propionate, ethyl ethoxy propionate, ethylene glycol methyl ether, ethylene Glycol ethyl ether, ethylene glycol-n-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol-n-butyl ether (butyl cellosolve), ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether , Diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, di Isobutyl ketone, isoamyl propionate, isoamyl isobutyrate, di-isopentyl ether, ethylene carbonate, propylene carbonate, and the like. These can be used independently, or can mix and use 2 or more types.

본 발명의 액정 배향제에 있어서의 고형분 농도(액정 배향제의 용매 이외의 성분의 합계 중량이 액정 배향제의 전체 중량에서 차지하는 비율)는, 점성, 휘발성 등을 고려하여 적절히 선택되지만, 바람직하게는 1∼10중량%의 범위이다. 즉, 본 발명의 액정 배향제는, 후술하는 바와 같이 기판 표면에 도포되어, 바람직하게는 가열됨으로써 액정 배향막인 도막 또는 액정 배향막이 되는 도막이 형성되지만, 고형분 농도가 1중량% 미만인 경우에는, 이 도막의 막두께가 과소하게 되어 양호한 액정 배향막을 얻을 수 없고, 한편 고형분 농도가 10중량%를 초과하는 경우에는, 도막의 막두께가 과대하게 되어 양호한 액정 배향막을 얻을 수 없고, 또한, 액정 배향제의 점성이 증대하여 도포 특성이 떨어지는 것이 된다. Although solid content concentration (the ratio which the total weight of components other than the solvent of a liquid crystal aligning agent occupies in the total weight of a liquid crystal aligning agent) in the liquid crystal aligning agent of this invention is selected suitably in consideration of viscosity, volatility, etc., Preferably It is the range of 1-10 weight%. That is, the liquid crystal aligning agent of this invention is apply | coated to the surface of a board | substrate as mentioned later, Preferably, the coating film which becomes a coating film which is a liquid crystal aligning film, or a liquid crystal aligning film is formed by heating, However, when solid content concentration is less than 1 weight%, this coating film When the film thickness of the film becomes too small to obtain a good liquid crystal alignment film, and on the other hand, when the solid content concentration exceeds 10% by weight, the film thickness of the coating film becomes excessive and a good liquid crystal alignment film cannot be obtained. Viscosity increases and application characteristics are inferior.

특히 바람직한 고형분 농도의 범위는, 기판에 액정 배향제를 도포할 때에 이용하는 방법에 따라 상이하다. 예를 들면 스피너법에 의한 경우에는 고형분 농도 1.5∼4.5중량%의 범위가 특히 바람직하다. 인쇄법에 의한 경우에는, 고형분 농도를 3∼9중량%의 범위로 하고, 그에 따라 용액 점도를 12∼50mPa·s의 범위로 하는 것이 특히 바람직하다. 잉크젯법에 의한 경우에는, 고형분 농도를 1∼5중량%의 범위로 하고, 그에 따라, 용액 점도를 3∼15mPa·s의 범위로 하는 것이 특히 바람직하다. The range of especially preferable solid content concentration changes with the method used when apply | coating a liquid crystal aligning agent to a board | substrate. For example, in the case of a spinner method, the range of 1.5 to 4.5 weight% of solid content concentration is especially preferable. In the case of the printing method, it is particularly preferable that the solid content concentration is in the range of 3 to 9% by weight, and the solution viscosity is in the range of 12 to 50 mPa · s. When using the inkjet method, it is especially preferable to make solid content concentration into the range of 1 to 5 weight%, and to make solution viscosity into the range of 3-15 mPa * s.

본 발명의 액정 배향제를 조제할 때의 온도는, 바람직하게는 10∼50℃이고, 보다 바람직하게는 20∼30℃이다. The temperature at the time of preparing the liquid crystal aligning agent of this invention becomes like this. Preferably it is 10-50 degreeC, More preferably, it is 20-30 degreeC.

<액정 표시 소자> <Liquid crystal display element>

본 발명의 액정 표시 소자는, 상기와 같은 본 발명의 액정 배향제로 형성된 액정 배향막을 구비하는 것이다. 보다 상세하게는, 본 발명의 액정 표시 소자는, 액정 셀의 양(兩) 외면에 편광판을 배치하여 이루어지는 것으로서, 당해 액정 셀은, 액정 배향막을 갖는 기판의 2매를 각 액정 배향막면이 상대하도록 대향 배치한 간극에 액정층을 협지한 구성을 갖고, 그리고 상기 액정 배향막이 본 발명의 액정 배향제로 형성된 것인 것을 특징으로 한다. The liquid crystal display element of this invention is equipped with the liquid crystal aligning film formed from the above-mentioned liquid crystal aligning agent of this invention. In more detail, the liquid crystal display element of this invention consists of arrange | positioning a polarizing plate in the both outer surface of a liquid crystal cell, and the said liquid crystal cell is made so that each liquid crystal aligning film surface may face two sheets of the board | substrate which has a liquid crystal aligning film. It has a structure which clamped the liquid crystal layer in the clearance gap which opposes, and the said liquid crystal aligning film is formed from the liquid crystal aligning agent of this invention, It is characterized by the above-mentioned.

이러한 본 발명의 액정 표시 소자는, 예를 들면 이하 (1) 내지 (3)의 공정에 의해 제조할 수 있다. 공정 (1)은, 소망하는 동작 모드에 따라 사용 기판이 상이하다. 공정 (2) 및 (3)은 각 동작 모드에 공통이다. Such a liquid crystal display element of this invention can be manufactured by the process of the following (1)-(3), for example. In the step (1), the substrate used differs depending on the desired operation mode. Steps (2) and (3) are common to each operation mode.

(1) 우선 기판 상에 본 발명의 액정 배향제를 도포하고, 이어서 도포면을 가열함으로써 기판 상에 도막을 형성한다. (1) First, the liquid crystal aligning agent of this invention is apply | coated on a board | substrate, and then a coating film is formed on a board | substrate by heating a coating surface.

(1-1) TN형, STN형 또는 VA형 액정 표시 소자를 제조하는 경우, 패터닝된 투명 도전막이 편면에 형성되어 있는 기판 2매를 한 쌍으로 하고, 그 각 투명 도전막 형성면 상에, 본 발명의 액정 배향제를, 바람직하게는 오프셋 인쇄법, 스핀 코팅법 또는 잉크젯 인쇄법에 의해 각각 도포하고, 이어서, 각 도포면을 가열함으로써 도막을 형성한다. 여기에, 기판으로서는, 예를 들면 플로트 유리, 소다 유리 등의 유리; 폴리에틸렌테레프탈레이트, 폴리부틸렌테레프탈레이트, 폴리에테르술폰, 폴리카보네이트, 폴리(지환식 올레핀) 등의 플라스틱으로 이루어지는 투명 기판을 이용할 수 있다. 기판의 편면에 형성되는 투명 도전막으로서는, 산화 주석(SnO2)으로 이루어지는 NESA막(미국 PPG사 등록 상표), 산화 인듐-산화 주석(In2O3-SnO2)으로 이루어지는 ITO막 등을 이용할 수 있고, 패터닝된 투명 도전막을 얻으려면, 예를 들면 패턴 없는 투명 도전막을 형성한 후 포토·에칭에 의해 패턴을 형성하는 방법, 투명 도전막을 형성할 때에 소망하는 패턴을 갖는 마스크를 이용하는 방법 등에 의할 수 있다. 액정 배향제의 도포시에는, 기판 표면 및 투명 도전막과 도막과의 접착성을 더욱 양호하게 하기 위해, 기판 표면 중 도막을 형성해야 하는 면에, 관능성 실란 화합물, 관능성 티탄 화합물 등을 미리 도포하는 전(前)처리를 시행해 두어도 좋다. (1-1) When manufacturing a TN type, STN type, or VA type liquid crystal display element, two board | substrates with which the patterned transparent conductive film is formed in one side are made into a pair, and on each transparent conductive film formation surface, The liquid crystal aligning agent of this invention is apply | coated preferably by the offset printing method, the spin coating method, or the inkjet printing method, respectively, and then a coating film is formed by heating each application surface. Here, as a board | substrate, For example, glass, such as float glass and a soda glass; A transparent substrate made of plastic such as polyethylene terephthalate, polybutylene terephthalate, polyether sulfone, polycarbonate, and poly (alicyclic olefin) can be used. As the transparent conductive film formed on one side of the substrate, an NESA film (registered trademark of PPG Co., Ltd.) made of tin oxide (SnO 2 ), an ITO film made of indium tin oxide (In 2 O 3 -SnO 2 ), or the like can be used. In order to obtain a patterned transparent conductive film, for example, by forming a patternless transparent conductive film and then forming a pattern by photo-etching, using a mask having a desired pattern when forming the transparent conductive film, or the like can do. At the time of coating of the liquid crystal aligning agent, in order to further improve the adhesion between the substrate surface and the transparent conductive film and the coating film, a functional silane compound, a functional titanium compound, and the like are previously added to the surface on which the coating film should be formed on the substrate surface. The pretreatment to apply may be performed.

액정 배향제 도포 후, 도포한 배향제의 액흐름 방지 등의 목적에서, 바람직하게는 예비 가열(프리베이킹)이 시행된다. 프리베이킹 온도는 바람직하게는 30∼200℃이고, 보다 바람직하게는 40∼150℃이고, 특히 바람직하게는 40∼100℃이다. 프리베이킹 시간은 바람직하게는 0.25∼10분이고, 보다 바람직하게는 0.5∼5분이다. 그 후, 용매를 완전히 제거하고, 필요에 따라서 폴리암산을 열이미드화하는 것을 목적으로 하여 소성(포스트베이킹) 공정이 실시된다. 이 소성(포스트베이킹) 온도는 바람직하게는 80∼300℃이고, 보다 바람직하게는 120∼250℃이다. 포스트베이킹 시간은 바람직하게는 5∼200분이고, 보다 바람직하게는 10∼100분이다. 이와 같이 하여, 형성되는 막의 막두께는, 바람직하게는 0.001∼1㎛이고, 보다 바람직하게는 0.005∼0.5㎛이다. After application of the liquid crystal aligning agent, preliminary heating (prebaking) is preferably performed for the purpose of preventing liquid flow of the applied alignment agent. Prebaking temperature becomes like this. Preferably it is 30-200 degreeC, More preferably, it is 40-150 degreeC, Especially preferably, it is 40-100 degreeC. Prebaking time becomes like this. Preferably it is 0.25-10 minutes, More preferably, it is 0.5-5 minutes. Thereafter, the solvent is completely removed, and a firing (postbaking) step is performed for the purpose of thermally imidating the polyamic acid as necessary. This baking (post-baking) temperature becomes like this. Preferably it is 80-300 degreeC, More preferably, it is 120-250 degreeC. Post-baking time becomes like this. Preferably it is 5-200 minutes, More preferably, it is 10-100 minutes. Thus, the film thickness of the film formed becomes like this. Preferably it is 0.001-1 micrometer, More preferably, it is 0.005-0.5 micrometer.

(1-2) 한편, 횡전계 방식의 액정 표시 소자를 제조하는 경우, 빗살형으로 패터닝된 투명 도전막이 편면에 형성되어 있는 기판의 도전막 형성면과, 도전막이 형성되어 있지 않은 대향 기판의 편면에, 본 발명의 액정 배향제를 각각 도포하고, 이어서 각 도포면을 가열함으로써 도막을 형성한다. (1-2) On the other hand, when manufacturing a transverse electric field type liquid crystal display element, the conductive film formation surface of the board | substrate with which the comb-shaped patterned transparent conductive film was formed in the single side | surface, and the single side | surface of the opposing board | substrate in which the conductive film is not formed is provided. The liquid crystal aligning agent of this invention is apply | coated to each, and then a coating film is formed by heating each application surface.

이때 사용되는 기판 및 투명 도전막의 재질, 투명 도전막의 패터닝 방법, 기판의 전처리, 액정 배향제의 도포 방법, 액정 배향제를 도포한 후의 가열 방법 그리고 형성되는 도막의 막두께에 대해서는 상기 (1-1)과 동일하다. In this case, the material of the substrate and the transparent conductive film, the patterning method of the transparent conductive film, the pretreatment of the substrate, the coating method of the liquid crystal aligning agent, the heating method after applying the liquid crystal aligning agent, and the film thickness of the formed coating film are described in (1-1). Same as).

(2) 본 발명의 방법에 의해 제조되는 액정 표시 소자가 VA형의 액정 표시 소자인 경우에는, 상기와 같이 하여 형성된 도막을 그대로 액정 배향막으로서 사용할 수 있지만, 소망하는 바에 따라서 다음에 서술하는 러빙 처리를 행한 후에 사용에 제공해도 좋다. (2) When the liquid crystal display element manufactured by the method of this invention is a VA type liquid crystal display element, although the coating film formed as mentioned above can be used as a liquid crystal aligning film as it is, the rubbing process mentioned next as needed as needed. You may provide for use after performing this.

한편, VA형 이외의 액정 표시 소자를 제조하는 경우에는, 상기와 같이 하여 형성된 도막에 러빙 처리를 시행함으로써 액정 배향막으로 한다. On the other hand, when manufacturing liquid crystal display elements other than VA type, a rubbing process is given to the coating film formed as mentioned above, and it is set as a liquid crystal aligning film.

러빙 처리는, 상기와 같이 하여 형성된 도막면에 대하여, 예를 들면 나일론, 레이온, 코튼 등의 섬유로 이루어지는 천을 감은 롤로 일정 방향으로 문지름으로써 행할 수 있다. 이에 따라, 액정 분자의 배향능이 도막에 부여되어 액정 배향막이 된다. The rubbing treatment can be performed by rubbing in a predetermined direction with a roll wound with a cloth made of fibers such as nylon, rayon, cotton and the like on the coating film surface formed as described above. Thereby, the orientation ability of a liquid crystal molecule is provided to a coating film, and it becomes a liquid crystal aligning film.

또한, 상기와 같이 하여 형성된 액정 배향막에 대하여, 예를 들면 액정 배향막의 일부에 자외선을 조사함으로써 액정 배향막의 일부 영역의 프리틸트각을 변화시키는 처리(특허문헌 11(일본공개특허공보 평6-222366호)및 특허문헌 12(일본공개특허공보 평6-281937호) 참조), 액정 배향막 표면의 일부에 레지스트막을 형성한 후에 앞선 러빙 처리와 상이한 방향으로 러빙 처리를 행한 후에 레지스트막을 제거하는 처리를 행하여, 액정 배향막이 영역마다 상이한 액정 배향능을 갖도록 함으로써 얻어지는 액정 표시 소자의 시계(視界) 특성을 개선하는 것(특허문헌 13(일본공개특허공보 평5-107544호) 참조) 등이 가능하다. Moreover, the process which changes the pretilt angle of a some area | region of a liquid crystal aligning film by irradiating an ultraviolet-ray to a part of liquid crystal aligning film, for example with respect to the liquid crystal aligning film formed as mentioned above (patent document 11 (Japanese Patent Laid-Open No. 6-222366). No.) and Patent Document 12 (Japanese Patent Laid-Open No. Hei 6-281937)), after forming a resist film on a part of the surface of the liquid crystal alignment film, a rubbing treatment is performed in a direction different from the preceding rubbing treatment, and then a resist film is removed. It is possible to improve the field of view characteristics of the liquid crystal display device obtained by making the liquid crystal alignment film have different liquid crystal alignment ability for each region (see Patent Document 13 (Japanese Patent Laid-Open No. 5-107544)).

(3) 상기와 같이 하여 액정 배향막이 형성된 기판을 2매 준비하고, 대향 배치한 2매의 기판 간에 액정을 배치함으로써, 액정 셀을 제조한다. 여기에서, 도막에 대하여 러빙 처리를 행한 경우에는, 2매의 기판은, 각 도막에 있어서의 러빙 방향이 서로 소정의 각도, 예를 들면 직교 또는 역평행이 되도록 대향 배치된다. (3) The liquid crystal cell is manufactured by preparing two board | substrates with a liquid crystal aligning film as mentioned above, and arrange | positioning a liquid crystal between two board | substrates which oppose. Here, when the rubbing process is performed with respect to a coating film, two board | substrates are mutually arrange | positioned so that the rubbing direction in each coating film may mutually become a predetermined angle, for example, orthogonal or antiparallel.

액정 셀을 제조하려면, 예를 들면 이하의 2가지 방법을 들 수 있다. In order to manufacture a liquid crystal cell, the following two methods are mentioned, for example.

제1 방법은, 종래부터 알려져 있는 방법이다. 우선, 각각의 액정 배향막이 대향되도록 간극(셀 갭)을 통하여 2매의 기판을 대향 배치하고, 2매의 기판의 주변부를 시일제를 이용하여 접합하고, 기판 표면 및 시일제에 의해 구획된 셀 갭 내에 액정을 주입 충전한 후, 주입공을 봉지함으로써, 액정 셀을 제조할 수 있다. The first method is a conventionally known method. First, two substrates are disposed to face each other through a gap (cell gap) so that the respective liquid crystal alignment films face each other, and the peripheral portions of the two substrates are bonded together using a sealing agent, and the cells partitioned by the substrate surface and the sealing agent. After the liquid crystal is injected and filled into the gap, the liquid crystal cell can be manufactured by sealing the injection hole.

제2 방법은, ODF(One Drop Fill) 방식이라고 불리는 수법이다. 액정 배향막을 형성한 2매의 기판 중 한쪽의 기판 상의 소정의 장소에 예를 들면 자외광 경화성의 시일제를 도포하고, 추가로 액정 배향막면 상의 소정에 수 개소에 액정을 적하한 후, 액정 배향막이 대향되도록 다른 한쪽의 기판을 접합함과 함께 액정을 기판의 전체면에 펴 바르고, 이어서 기판의 전체면에 자외광을 조사하여 시일제를 경화함으로써, 액정 셀을 제조할 수 있다. The second method is a method called an ODF (One Drop Fill) method. After apply | coating an ultraviolet-ray curable sealing compound, for example to the predetermined place on one board | substrate among two board | substrates which formed the liquid crystal aligning film, and further dropping a liquid crystal in several places on the liquid crystal aligning film surface, a liquid crystal aligning film A liquid crystal cell can be manufactured by bonding another board | substrate so that this may oppose, spreading a liquid crystal on the whole surface of a board | substrate, then irradiating an ultraviolet light to the whole surface of a board | substrate, and hardening a sealing compound.

어느 방법에 의한 경우라도, 상기와 같이 하여 제조한 액정 셀에 대해서, 이어서, 이용한 액정이 등방상(等方相)을 취하는 온도까지 가열한 후, 실온까지 서서히 냉각함으로써, 액정 주입시의 유동 배향을 제거하는 것이 바람직하다. Even in the case of any of the methods, the liquid crystal cell produced as described above is subsequently heated to a temperature at which the used liquid crystal takes an isotropic phase, and then gradually cooled to room temperature, thereby allowing flow orientation during liquid crystal injection. It is desirable to remove.

그리고, 액정 셀의 외측 표면에 편광판을 접합함으로써, 본 발명의 액정 표시 소자를 얻을 수 있다. And the liquid crystal display element of this invention can be obtained by bonding a polarizing plate to the outer surface of a liquid crystal cell.

여기에서, 시일제로서는, 예를 들면 경화제 및 스페이서로서의 산화 알루미늄구(球)를 함유하는 에폭시 수지 등을 이용할 수 있다. Here, as a sealing agent, the epoxy resin etc. which contain the hardening agent and the aluminum oxide sphere as a spacer can be used, for example.

상기 액정으로서는, 예를 들면 네마틱형 액정, 스멕틱형 액정 등을 이용할 수 있고, 이들 중 네마틱형 액정이 바람직하며, 예를 들면 시프베이스계 액정, 아족시계 액정, 비페닐계 액정, 페닐사이클로헥산계 액정, 에스테르계 액정, 테르페닐계 액정, 비페닐사이클로헥산계 액정, 피리미딘계 액정, 디옥산계 액정, 바이사이클로옥탄계 액정, 쿠반계 액정 등을 이용할 수 있다. 또한, 이들 액정에, 예를 들면 콜레스테릴클로라이드, 콜레스테릴노나에이트, 콜레스테릴카보네이트 등의 콜레스테릭 액정; 상품명 C-15, CB-15(메르크사 제조)로서 판매되고 있는 것과 같은 키랄제; p-데실옥시벤질리덴-p-아미노-2-메틸부틸신나메이트 등의 강(强)유전성 액정 등을 추가로 첨가하여 사용해도 좋다. As said liquid crystal, a nematic liquid crystal, a smectic liquid crystal, etc. can be used, for example, a nematic liquid crystal is preferable among these, For example, a siphon base liquid crystal, a subfamily clock liquid crystal, a biphenyl liquid crystal, a phenyl cyclohexane type A liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenyl cyclohexane type liquid crystal, a pyrimidine type liquid crystal, a dioxane type liquid crystal, a bicyclooctane type liquid crystal, a cuban type liquid crystal, etc. can be used. Moreover, for these liquid crystals, For example, cholesteric liquid crystals, such as cholesteryl chloride, cholesteryl nonaate, cholesteryl carbonate; Chiral agents such as those sold under the trade names C-15 and CB-15 (manufactured by Merck); Strong dielectric liquid crystals such as p-decyloxybenzylidene-p-amino-2-methylbutylcinnamate may be further added and used.

액정 셀의 외표면에 접합되는 편광판으로서는, 폴리비닐알코올을 연신 배향시키면서 요오드를 흡수시킨 「H막」이라고 칭해지는 편광막을 아세트산 셀룰로오스 보호막 사이에 끼운 편광판 또는 H막 그 자체로 이루어지는 편광판을 들 수 있다. As a polarizing plate bonded to the outer surface of a liquid crystal cell, the polarizing plate which consists of a polarizing plate called "H film" which absorbed iodine while extending | stretching polyvinyl alcohol, and sandwiched between the cellulose acetate protective films, or the H film itself is mentioned. .

(실시예)(Example)

이하, 본 발명을 실시예에 의해 더욱 구체적으로 설명하지만, 본 발명은 이들 실시예에 제한되는 것은 아니다. 중합예에 있어서의 각 중합체 용액의 용액 점도 및 폴리이미드의 이미드화율은 이하의 방법에 의해 측정했다. Hereinafter, although an Example demonstrates this invention further more concretely, this invention is not restrict | limited to these Examples. The solution viscosity of each polymer solution in a polymerization example, and the imidation ratio of polyimide were measured by the following method.

[중합체 용액의 용액 점도] [Solution Viscosity of Polymer Solution]

중합체 용액의 용액 점도(mPa·s)는, 각 합성예에 기재된 용매 및 농도에 있어서, E형 회전 점도계를 이용하여 25℃에서 측정했다. The solution viscosity (mPa * s) of the polymer solution was measured at 25 degreeC using the E-type rotational viscometer in the solvent and concentration described in each synthesis example.

[폴리이미드의 이미드화율] [Imidation Rate of Polyimide]

폴리이미드의 용액을 소량 분취하여 순수(純水)에 투입하고, 얻어진 침전을 실온에서 충분히 감압 건조한 후, 중수소화 디메틸술폭사이드에 용해하고, 테트라메틸실란을 기준 물질로 하여 실온에서 1H-NMR을 측정했다. 얻어진 1H-NMR 스펙트럼으로부터, 하기 수식 (1)로 나타나는 식에 의해 이미드화율을 구했다. A small amount of the polyimide solution was collected and poured into pure water. The precipitate obtained was dried under reduced pressure at room temperature, and then dissolved in deuterated dimethyl sulfoxide. The tetramethylsilane was used as reference material at room temperature for 1 H-NMR. Was measured. H-NMR spectrum obtained from the first, to the imidization ratio was calculated according to the equation represented by the formula (1).

이미드화율(%)=(1-A1/A2×α)×100 (1) Imidation ratio (%) = (1-A 1 / A 2 × α) × 100 (1)

(수식 (1) 중, A1은 화학 시프트 10ppm 부근에 나타나는 NH기의 프로톤 유래의 피크 면적이고, (In Formula (1), A 1 is the peak area derived from the proton of the NH group which appears in the vicinity of 10 ppm of chemical shift,

A2는 그 외의 프로톤 유래의 피크 면적이고, A 2 is the peak area derived from other protons,

α는 중합체의 전구체(폴리암산)에 있어서의 NH기의 프로톤 1개에 대한 그 외의 프로톤의 개수 비율임) α is the number ratio of the other protons to one proton of the NH group in the precursor (polyamic acid) of the polymer)

<TN형 액정 배향제용 중합체의 합성 및 안정성 평가> <Synthesis and stability evaluation of the polymer for TN type liquid crystal aligning agent>

[특정 중합체로서의 폴리암산의 합성예] [Synthesis example of polyamic acid as a specific polymer]

합성예 A-TN1 Synthesis Example A-TN1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 피로멜리트산 2무수물 109g(0.50몰) 그리고 디아민으로서 4,4'-디아미노디페닐메탄 198g(1.0몰)을, N-메틸-2-피롤리돈 246g 및 γ-부티로락톤 2,213g으로 이루어지는 혼합 용매에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-TN1)을 15중량% 함유하는 용액을 얻었다. 이 용액의 용액 점도는 179mPa·s였다. 112 g (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride as tetracarboxylic dianhydride and 109 g (0.50 mol) of pyromellitic dianhydride and 4,4'-diaminodiphenylmethane as diamine Polyamic acid (A-TN1) by dissolving 198 g (1.0 mol) in a mixed solvent consisting of 246 g of N-methyl-2-pyrrolidone and 2,213 g of γ-butyrolactone and reacting at 40 ° C for 3 hours. The solution containing 15 weight% of was obtained. The solution viscosity of this solution was 179 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 A-TN2 Synthesis Example A-TN2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 67g(0.30몰) 및 피로멜리트산 2무수물 153g(0.70몰) 그리고 디아민으로서 4,4'-디아미노디페닐메탄 198g(1.0몰)을, N-메틸-2-피롤리돈 246g 및 γ-부티로락톤 2,213g으로 이루어지는 혼합 용매에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-TN2)을 15중량% 함유하는 용액을 얻었다. 이 용액의 용액 점도는 153mPa·s였다. 67 g (0.30 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 153 g (0.70 mol) of pyromellitic dianhydride and 4,4'-diaminodiphenylmethane as diamine Polyamic acid (A-TN2) by dissolving 198 g (1.0 mol) in a mixed solvent consisting of 246 g of N-methyl-2-pyrrolidone and 2,213 g of γ-butyrolactone, and reacting at 40 ° C for 3 hours. The solution containing 15 weight% of was obtained. The solution viscosity of this solution was 153 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[기타 폴리암산의 합성예] [Synthesis example of other polyamic acid]

합성예 a-TN3 Synthesis Example a-TN3

테트라카본산 2무수물로서 피로멜리트산 2무수물 109g(0.50몰) 및 1,2,3,4-사이클로부탄테트라카본산 2무수물 98g(0.50몰) 그리고 디아민으로서 4,4'-디아미노디페닐메탄 198g(1.0몰)을, N-메틸-2-피롤리돈 230g 및 γ-부티로락톤 2,068g으로 이루어지는 혼합 용매에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-TN3)을 15중량% 함유하는 용액을 얻었다. 이 용액의 용액 점도는 193mPa·s였다. 109 g (0.50 mol) of pyromellitic dianhydride as tetracarboxylic dianhydride and 98 g (0.50 mol) of 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 4,4'-diaminodiphenylmethane as diamine Polyamic acid (a-TN3) by dissolving 198 g (1.0 mol) in a mixed solvent consisting of 230 g of N-methyl-2-pyrrolidone and 2,068 g of γ-butyrolactone and reacting at 40 ° C for 3 hours. The solution containing 15 weight% of was obtained. The solution viscosity of this solution was 193 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[특정 중합체로서의 폴리이미드의 합성예] [Synthesis example of polyimide as a specific polymer]

합성예 B-TN1 Synthesis Example B-TN1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 p-페닐렌디아민 106g(0.985몰) 및 3-(3,5-디아미노벤조일옥시) 콜레스탄 7.8g(0.015몰)을 N-메틸-2-피롤리돈 3,042g에 용해하여, 60℃에서 6시간 반응을 행함으로써, 폴리암산을 함유하는 용액을 얻었다. 여기에서 얻어진 폴리암산 용액의 용액 점도는 160mPa·s였다. 112 g (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and p- as diamine 106 g (0.985 mole) of phenylenediamine and 7.8 g (0.015 mole) of 3- (3,5-diaminobenzoyloxy) cholestan are dissolved in 3,042 g of N-methyl-2-pyrrolidone, and 6 hours at 60 ° C. By reacting, the solution containing polyamic acid was obtained. The solution viscosity of the polyamic acid solution obtained here was 160 mPa · s.

얻어진 폴리암산 용액에, N-메틸-2-피롤리돈 3,380g을 추가하고, 피리딘 395g 및 무수 아세트산 306g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계(系) 내의 용매를 새로운 γ-부티로락톤으로 용매 치환하고(본 조작에서 이미드화 반응에 사용한 피리딘 및 무수 아세트산을 계 외로 제거함, 이하 동일), 추가로 농축함으로써, 이미드화율 약 94%의 폴리이미드(B-TN1)를 10중량% 함유하는 용액을 얻었다. 3,380 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 395 g of pyridine and 306 g of acetic anhydride were added, and the dehydration ring-closure reaction was performed at 110 degreeC for 4 hours. After the dehydration ring closure reaction, the solvent in the system is solvent-substituted with fresh γ-butyrolactone (the pyridine and acetic anhydride used in the imidation reaction in this operation are removed to the outside of the system, hereinafter the same), and further concentrated. A solution containing 10% by weight of polyimide (B-TN1) having a dehydration rate of about 94% was obtained.

이 용액을 소량 분취하여, γ-부티로락톤을 더하여 농도 6중량%의 용액으로 하여 측정한 용액 점도는 28mPa·s였다. The solution viscosity was fractionated and the solution viscosity measured as a solution of 6 weight% of the addition of (gamma) -butyrolactone was 28 mPa * s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[기타 폴리이미드의 합성예] [Synthesis example of other polyimide]

합성예 b-TN2 Synthesis Example b-TN2

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 110g(0.50몰) 및 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)나프토[1,2-c]푸란-1,3-디온 155g(0.50몰), 디아민으로서 p-페닐렌디아민 92g(0.87몰), 비스아미노프로필테트라메틸디실록산 25g(0.10몰) 및 3,6-비스(4-아미노벤조일옥시)콜레스탄 13g(0.02몰) 그리고 모노아민으로서 아닐린 2.7g(0.030몰)을 N-메틸-2-피롤리돈 960g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산을 함유하는 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 59mPa·s였다. 110 g (0.50 mol) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride and 1,3,3a, 4,5,9b-hexahydro-8-methyl-5- (tetrahydro-) as tetracarboxylic dianhydride 155 g (0.50 mol) of 2,5-dioxo-3-furanyl) naphtho [1,2-c] furan-1,3-dione, 92 g (0.87 mol) of p-phenylenediamine as diamine, bisaminopropyl 25 g (0.10 mol) of tetramethyldisiloxane and 13 g (0.02 mol) of 3,6-bis (4-aminobenzoyloxy) cholestane and 2.7 g (0.030 mol) of aniline as monoamine were added to N-methyl-2-pyrrolidone. It melt | dissolved in 960g and reacted at 60 degreeC for 6 hours, and obtained the solution containing polyamic acid. The solution viscosity measured as a small amount of the obtained polyamic acid solution, the addition of N-methyl- 2-pyrrolidone and making it the solution of 10 weight% of polyamic acid concentration was 59 mPa * s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 2,700g을 추가하고, 피리딘 396g 및 무수 아세트산 409g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 γ-부티로락톤으로 용매 치환하고, 추가로 농축함으로써, 이미드화율 약 95%의 폴리이미드(b-TN2)를 15중량% 함유하는 용액 약 2,520g을 얻었다. 이 폴리이미드 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 6.0중량%의 용액으로 하여 측정한 용액 점도는 18mPa·s였다. Subsequently, 2,700 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 396 g of pyridine and 409 g of acetic anhydride were added, and dehydration ring closing was performed at 110 degreeC for 4 hours. After the dehydration ring closure reaction, the solvent in the system was solvent-substituted with fresh γ-butyrolactone, and further concentrated, whereby about 2,520 g of a solution containing 15 wt% of polyimide (b-TN2) having an imidization ratio of about 95% was obtained. Got it. A small amount of this polyimide solution was collected, and the solution viscosity measured as a solution having a polyimide concentration of 6.0% by weight by adding γ-butyrolactone was 18 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 b-TN3 Synthesis Example b-TN3

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 224g(1.0몰) 그리고 디아민으로서 p-페닐렌디아민 106g(0.985몰) 및 3-(3,5-디아미노벤조일옥시)콜레스탄 7.8g(0.015몰)을 N-메틸-2-피롤리돈 3,042g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산을 함유하는 용액을 얻었다. 여기에서 얻어진 폴리암산 용액의 용액 점도는 181mPa·s였다. 224 g (1.0 mol) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as tetracarboxylic dianhydride and 106 g (0.985 mol) of p-phenylenediamine as diamine and 3- (3,5-diaminobenzoyloxy) 7.8 g (0.015 mol) of cholestan was dissolved in 3,042 g of N-methyl-2-pyrrolidone, and reacted at 60 degreeC for 6 hours, and the solution containing polyamic acid was obtained. The solution viscosity of the polyamic acid solution obtained here was 181 mPa · s.

얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,380g을 추가하고, 피리딘 395g 및 무수 아세트산 306g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 γ-부티로락톤으로 용매 치환하고, 추가로 농축함으로써, 이미드화율 약 95%의 폴리이미드(b-TN3)를 10중량% 함유하는 용액을 얻었다. 3,380 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 395 g of pyridine and 306 g of acetic anhydride were added, and the dehydration ring-closure reaction was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh γ-butyrolactone and further concentrated to obtain a solution containing 10% by weight of polyimide (b-TN3) having an imidization ratio of about 95%.

이 용액을 소량 분취하여, γ-부티로락톤을 더하여 농도 6중량%의 용액으로 하여 측정한 용액 점도는 35mPa·s였다. A small amount of this solution was collected, and the solution viscosity measured as a solution having a concentration of 6% by weight by adding γ-butyrolactone was 35 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

<VA형 액정 배향제용 중합체의 합성 및 안정성 평가> <Synthesis and stability evaluation of the polymer for VA type liquid crystal aligning agent>

[특정 중합체로서의 폴리이미드의 합성예] [Synthesis example of polyimide as a specific polymer]

합성예 B-VA1Synthesis Example B-VA1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 52g(0.1몰), 콜레스타닐옥시-2,4-디아미노벤젠 49g(0.1몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,652g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 79mPa·s였다. 112 g (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and 3, as diamine 52 g (0.1 mole) of 5-diaminobenzoic acid cholestanyl, 49 g (0.1 mole) of cholestanyloxy-2,4-diaminobenzene and 87 g (0.80 mole) of p-phenylenediamine were N-methyl-2-pi It melt | dissolved in 1,652 g of ralidones, and it reacted at 60 degreeC for 6 hours, and obtained the polyamic acid solution. The solution viscosity measured as a small amount of the obtained polyamic-acid solution, the addition of N-methyl- 2-pyrrolidone as a solution of 10 weight% of polymer concentrations, was 79 mPa * s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,835g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 51%의 폴리이미드(B-VA1)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 102mPa·s였다. Subsequently, 3,835 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closing was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA1) having an imidation ratio of about 51%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 102 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-VA2 Synthesis Example B-VA2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 52g(0.1몰), 콜레스타닐옥시-2,4-디아미노벤젠 49g(0.1몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,652g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 71mPa·s였다. 112 g (0.50 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and 3, as diamine 52 g (0.1 mole) of 5-diaminobenzoic acid cholestanyl, 49 g (0.1 mole) of cholestanyloxy-2,4-diaminobenzene and 87 g (0.80 mole) of p-phenylenediamine were N-methyl-2-pi It melt | dissolved in 1,652 g of ralidones, and it reacted at 60 degreeC for 6 hours, and obtained the polyamic acid solution. A small amount of the obtained polyamic acid solution was aliquoted, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 71 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,835g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 48%의 폴리이미드(B-VA2)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 99mPa·s였다. Subsequently, 3,835 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closing was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA2) having an imidation ratio of about 48%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 99 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-VA3 Synthesis Example B-VA3

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 180g(0.80몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,663g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 59mPa·s였다. 45 g (0.20 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 180 g (0.80 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and 3, as diamine 105 g (0.20 mol) of 5-diaminobenzoic acid cholestanyl and 87 g (0.80 mol) of p-phenylenediamine were dissolved in 1,663 g of N-methyl-2-pyrrolidone and reacted at 60 ° C. for 6 hours to obtain poly A dark acid solution was obtained. The solution viscosity measured as a small amount of the obtained polyamic-acid solution, the addition of N-methyl- 2-pyrrolidone as a solution of 10 weight% of polymer concentrations, was 59 mPa * s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,861g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 47%의 폴리이미드(B-VA3)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 80mPa·s였다. Subsequently, 3,861 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closure was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA3) having an imidization ratio of about 47%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 80 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-VA4 Synthesis Example B-VA4

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 180g(0.80몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,663g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 66mPa·s였다. 45 g (0.20 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 180 g (0.80 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and 3, as diamine 105 g (0.20 mol) of 5-diaminobenzoic acid cholestanyl and 87 g (0.80 mol) of p-phenylenediamine were dissolved in 1,663 g of N-methyl-2-pyrrolidone and reacted at 60 ° C. for 6 hours to obtain poly A dark acid solution was obtained. The solution viscosity measured as a small amount of the obtained polyamic-acid solution, the addition of N-methyl- 2-pyrrolidone as a solution of 10 weight% of polymer concentrations, was 66 mPa * s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,861g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 50%의 폴리이미드(B-VA4)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 89mPa·s였다. Subsequently, 3,861 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closure was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA4) having an imidization ratio of 50%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 89 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-VA5 Synthesis Example B-VA5

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 135g(0.60몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 90g(0.40몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰), p-페닐렌디아민 65g(0.60몰) 및 3,5-디아미노벤조산 30g(0.20몰)을 N-메틸-2-피롤리돈 1,697g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 50mPa·s였다. 135 g (0.60 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride as tetracarboxylic dianhydride and 90 g (0.40 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and 3, as diamine 105 g (0.20 mol) of 5-diaminobenzoic acid cholestanyl, 65 g (0.60 mol) of p-phenylenediamine and 30 g (0.20 mol) of 3,5-diaminobenzoic acid were added to 1,697 g of N-methyl-2-pyrrolidone. It melt | dissolved and reacted at 60 degreeC for 6 hours, and obtained the polyamic acid solution. A small amount of the obtained polyamic acid solution was added, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 50 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,939g을 추가하고, 피리딘 119g 및 무수 아세트산 153g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 66%의 폴리이미드(B-VA5)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 79mPa·s였다. Subsequently, 3,939 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 119 g of pyridine and 153 g of acetic anhydride were added, and dehydration ring closure was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA5) having an imidization ratio of about 66%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 79 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-VA6 Synthesis Example B-VA6

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 179g(0.80몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 131g(0.25몰), p-페닐렌디아민 53g(0.50몰) 및 3,5-디아미노벤조산 38g(0.25몰)을 N-메틸-2-피롤리돈 1,697g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 58mPa·s였다. 45 g (0.20 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 179 g (0.80 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and 3, as diamine 131 g (0.25 mole) of 5-diaminobenzoic acid cholestanyl, 53 g (0.50 mole) of p-phenylenediamine and 38 g (0.25 mole) of 3,5-diaminobenzoic acid were added to 1,697 g of N-methyl-2-pyrrolidone. It melt | dissolved and reacted at 60 degreeC for 6 hours, and obtained the polyamic acid solution. A small amount of the obtained polyamic acid solution was aliquoted, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 58 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,939g을 추가하고, 피리딘 119g 및 무수 아세트산 153g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 69%의 폴리이미드(B-VA6)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 81mPa·s였다. Subsequently, 3,939 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 119 g of pyridine and 153 g of acetic anhydride were added, and dehydration ring closure was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA6) having an imidization ratio of about 69%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 81 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[기타 폴리이미드의 합성예] [Synthesis example of other polyimide]

합성예 b-VA7 Synthesis Example b-VA7

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 224g(1.0몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 52g(0.10몰), 콜레스타닐옥시-2,4-디아미노벤젠 49g(0.10몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,652g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 70mPa·s였다. 224 g (1.0 mol) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as tetracarboxylic dianhydride and 52 g (0.10 mol) of 3,5-diaminobenzoic acid cholestanyl as diamine, cholestanyloxy-2, 49 g (0.10 mol) of 4-diaminobenzene and 87 g (0.80 mol) of p-phenylenediamine were dissolved in 1,652 g of N-methyl-2-pyrrolidone and reacted at 60 ° C. for 6 hours to give a polyamic acid solution. Got it. The solution viscosity measured as a small amount of the obtained polyamic-acid solution, the addition of N-methyl- 2-pyrrolidone as a solution of 10 weight% of polymer concentrations, was 70 mPa * s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,835g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 49%의 폴리이미드(b-VA7)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 80mPa·s였다. Subsequently, 3,835 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closing was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (b-VA7) having an imidation ratio of about 49%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 80 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 b-VA8 Synthesis Example b-VA8

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 224g(1.0몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰), p-페닐렌디아민 65g(0.60몰) 및 3,5-디아미노벤조산 30g(0.20몰)을 N-메틸-2-피롤리돈 1,697g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 50mPa·s였다. 224 g (1.0 mol) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as tetracarboxylic dianhydride, 105 g (0.20 mol) of 3,5-diaminobenzoic acid cholestanyl as diamine, 65 g of p-phenylenediamine 0.60 mol) and 30 g (0.20 mol) of 3,5-diaminobenzoic acid were dissolved in 1,697 g of N-methyl-2-pyrrolidone, and reacted at 60 ° C. for 6 hours to obtain a polyamic acid solution. A small amount of the obtained polyamic acid solution was added, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 50 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,939g을 추가하고, 피리딘 119g 및 무수 아세트산 153g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 67%의 폴리이미드(b-VA8)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 73mPa·s였다. Subsequently, 3,939 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 119 g of pyridine and 153 g of acetic anhydride were added, and dehydration ring closure was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (b-VA8) having an imidization ratio of about 67%. A small amount of the obtained polyimide solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 73 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

<IPS형 액정 배향제용 중합체의 합성 및 안정성 평가> <Synthesis and stability evaluation of the polymer for IPS type liquid crystal aligning agent>

[특정 중합체로서의 폴리암산의 합성예] [Synthesis example of polyamic acid as a specific polymer]

합성예 A-IPS1 Synthesis Example A-IPS1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 피로멜리트산 2무수물 174g(0.80몰) 그리고 디아민으로서 p-페닐렌디아민 108g(1.0몰)을 N-메틸-2-피롤리돈 1,900g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-IPS1)을 15중량% 함유하는 용액을 얻었다. 45 g (0.20 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 174 g (0.80 mol) of pyromellitic dianhydride and 108 g (1.0 mol) of p-phenylenediamine as diamine Was dissolved in 1,900 g of N-methyl-2-pyrrolidone and reacted at 40 ° C. for 3 hours to obtain a solution containing 15% by weight of polyamic acid (A-IPS1).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 75mPa·s였다. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 75 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[기타 폴리암산의 합성예] [Synthesis example of other polyamic acid]

합성예 a-IPS2 Synthesis Example a-IPS2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 190g(0.85몰) 및 피로멜리트산 2무수물 33g(0.15몰)을 이용한 것 이외는, 합성예 A-IPS1과 동일하게 하여 폴리암산(a-IPS2)을 15중량% 함유하는 용액을 얻었다. Same as Synthesis Example A-IPS1 except that 190 g (0.85 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 33 g (0.15 mol) of pyromellitic dianhydride were used as tetracarboxylic dianhydride. The solution containing 15 weight% of polyamic acid (a-IPS2) was obtained.

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 63mPa·s였다. This solution was aliquoted in small amounts, and the solution viscosity measured as the solution of 10 weight% of polyamic acid concentration by adding N-methyl- 2-pyrrolidone was 63 mPa * s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화가 보여져, 보존 안정성은 불량했다. When this polymer solution was left to stand at 20 degreeC for 3 days, gelation was seen and the storage stability was poor.

이 폴리암산(a-IPS2)에 대해서는, 나머지 평가를 행하지 않았다. Regarding this polyamic acid (a-IPS2), remaining evaluation was not performed.

[특정 중합체로서의 폴리암산의 합성예] [Synthesis example of polyamic acid as a specific polymer]

합성예 A-IPS3 Synthesis Example A-IPS3

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 160g(0.80몰) 및 p-페닐렌디아민 110g(0.20몰)을 N-메틸-2-피롤리돈 2,300g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-IPS3)을 15중량% 함유하는 용액을 얻었다. 180 g (0.80 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mol) of pyromellitic dianhydride as tetracarboxylic dianhydride and 4,4'-diaminodiphenyl ether as diamine Polyamic acid (A-IPS3) was dissolved by dissolving 160 g (0.80 mol) and 110 g (0.20 mol) of p-phenylenediamine in 2,300 g of N-methyl-2-pyrrolidone and reacting at 40 ° C for 3 hours. The solution containing 15 weight% was obtained.

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 74mPa·s였다. A small amount of the solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 74 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 A-IPS4 Synthesis Example A-IPS4

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰)을 이용한 것 이외는 합성예 A-IPS3과 동일하게 하여 폴리암산(A-IPS4)을 15중량% 함유하는 용액을 얻었다. In the same manner as in Synthesis Example A-IPS3, except that 180 g (0.80 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mol) of pyromellitic dianhydride were used as tetracarboxylic dianhydride. To obtain a solution containing 15% by weight of polyamic acid (A-IPS4).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 60mPa·s였다. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 60 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 A-IPS5 Synthesis Example A-IPS5

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰) 그리고 디아민으로서 4,4'-디아미노디페닐아민 200g(1.0몰)을 N-메틸-2-피롤리돈 2,400g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-IPS5)을 15중량% 함유하는 용액을 얻었다. 180 g (0.80 mole) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mole) of pyromellitic dianhydride as tetracarboxylic dianhydride and 4,4'-diaminodiphenylamine as diamine 200 g (1.0 mole) was dissolved in 2,400 g of N-methyl-2-pyrrolidone and reacted at 40 ° C for 3 hours to obtain a solution containing 15% by weight of polyamic acid (A-IPS5).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 65mPa·s였다. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 65 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 A-IPS6 Synthesis Example A-IPS6

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 100g(0.50몰) 및 4,4'-디아미노디페닐아민 100g(0.50몰)을 각각 이용한 것 이외는 합성예 A-IPS5와 동일하게 하여 폴리암산(A-IPS6)을 15중량% 함유하는 용액을 얻었다. 180 g (0.80 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mol) of pyromellitic dianhydride as tetracarboxylic dianhydride and 4,4'-diaminodiphenyl ether as diamine A solution containing 15% by weight of polyamic acid (A-IPS6) in the same manner as in Synthesis Example A-IPS5 except that 100 g (0.50 mol) and 100 g (0.50 mol) of 4,4'-diaminodiphenylamine were used, respectively. Got.

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 70mPa·s였다. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 70 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[기타 폴리암산의 합성예] [Synthesis example of other polyamic acid]

합성예 a-IPS7 Synthesis Example a-IPS7

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 224g(1.0몰) 그리고 디아민으로서 p-페닐렌디아민 108g(1.0몰)을 N-메틸-2-피롤리돈 1,900g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS7)을 15중량% 함유하는 용액을 얻었다. 224 g (1.0 mole) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 108 g (1.0 mole) of p-phenylenediamine as diamine were added to N-methyl-2-pyrrolidone 1,900. It melt | dissolved in g and reacted at 40 degreeC for 3 hours, and obtained the solution containing 15 weight% of polyamic acid (a-IPS7).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 99mPa·s였다. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 99 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화가 관찰되어, 보존 안정성은 불량했다. When this polymer solution was left to stand at 20 degreeC for 3 days, gelation was observed and storage stability was poor.

이 폴리암산(a-IPS7)에 대해서는, 나머지 평가를 행하지 않았다. Regarding this polyamic acid (a-IPS7), the remaining evaluation was not performed.

합성예 a-IPS8 Synthesis Example a-IPS8

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 224g(1.0몰)을 이용한 것 이외는 합성예 A-IPS5와 동일하게 하여 폴리암산(a-IPS8)을 15중량% 함유하는 용액을 얻었다. Polyamic acid (a-IPS8) was weighed in the same manner as in Synthesis Example A-IPS5 except that 224 g (1.0 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride was used as tetracarboxylic dianhydride. The solution containing% was obtained.

이 용액은, 반응 온도(40℃)에서 용액 형상이었지만, 이것을 실온까지 냉각하는 과정에서 겔화가 발생했기 때문에, 점도를 측정할 수 없었다. Although this solution was in solution form at reaction temperature (40 degreeC), since gelation generate | occur | produced in the process of cooling this to room temperature, the viscosity was not able to be measured.

이 폴리암산(a-IPS8)에 대해서는, 나머지 평가를 행하지 않았다. Regarding this polyamic acid (a-IPS8), remaining evaluation was not performed.

합성예 a-IPS9 Synthesis Example a-IPS9

테트라카본산 2무수물로서 피로멜리트산 2무수물 220g(1.0몰) 및 디아민으로서 p-페닐렌디아민 110g(1.0몰)을 N-메틸-2-피롤리돈 1,800g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS9)을 15중량% 함유하는 용액을 얻었다. 220 g (1.0 mole) of pyromellitic dianhydride as tetracarboxylic dianhydride and 110 g (1.0 mole) of p-phenylenediamine as diamine were dissolved in 1,800 g of N-methyl-2-pyrrolidone, and 3 hours at 40 degreeC. By reacting, the solution containing 15 weight% of polyamic acid (a-IPS9) was obtained.

이 용액의 용액 점도는 180mPa·s였다. The solution viscosity of this solution was 180 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 a-IPS10 Synthesis Example a-IPS10

테트라카본산 2무수물로서 피로멜리트산 2무수물 220g(1.0몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 160g(0.80몰) 및 p-페닐렌디아민 22g(0.20몰)을 N-메틸-2-피롤리돈 2,300g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS10)을 15중량% 함유하는 용액을 얻었다. 220 g (1.0 mole) pyromellitic dianhydride as tetracarboxylic dianhydride and 160 g (0.80 mole) of 4,4'-diaminodiphenyl ether as diamine and 22 g (0.20 mole) of p-phenylenediamine as N-methyl- It dissolved in 2,300 g of 2-pyrrolidone and reacted at 40 degreeC for 3 hours, and the solution containing 15 weight% of polyamic acid (a-IPS10) was obtained.

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 71mPa·s였다. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 71 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 a-IPS11 Synthesis Example a-IPS11

테트라카본산 2무수물로서 피로멜리트산 2무수물 200g(0.90몰) 및 1,2,3,4-사이클로부탄테트라카본산 2무수물 20g(0.10몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 160g(0.80몰) 및 p-페닐렌디아민 22g(0.20몰)을 N-메틸-2-피롤리돈 2,300g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS11)을 15중량% 함유하는 용액을 얻었다. 200 g (0.90 mol) of pyromellitic dianhydride as tetracarboxylic dianhydride and 20 g (0.10 mol) of 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 4,4'-diaminodiphenyl ether as diamine 160 g (0.80 mole) and 22 g (0.20 mole) of p-phenylenediamine were dissolved in 2,300 g of N-methyl-2-pyrrolidone and reacted at 40 ° C. for 3 hours to produce polyamic acid (a-IPS11). The solution containing 15 weight% was obtained.

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 77mPa·s였다. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyamic acid concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 77 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[특정 중합체로서의 폴리이미드의 합성예] [Synthesis example of polyimide as a specific polymer]

합성예 B-IPS1 Synthesis Example B-IPS1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 p-페닐렌디아민 86g(0.80몰), 4,4'-디아미노디페닐메탄 23g(0.10몰) 및 4,4'-비스(트리플루오로메틸)비페닐 32g(0.10몰)을 N-메틸-2-피롤리돈 2,100g에 용해하여, 40℃에서 3시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여, 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 40mPa·s였다. 112 g (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and p- as diamine 86 g (0.80 mol) of phenylenediamine, 23 g (0.10 mol) of 4,4'-diaminodiphenylmethane and 32 g (0.10 mol) of 4,4'-bis (trifluoromethyl) biphenyl It melt | dissolved in 2,100 g of pyrrolidone, and reacted at 40 degreeC for 3 hours, and obtained the polyamic acid solution. A small amount of the obtained polyamic acid solution was added, N-methyl-2-pyrrolidone was added, and the solution viscosity measured as a solution of 10 weight% of polymer concentrations was 40 mPa * s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 2,800g을 추가하고, 피리딘 400g 및 무수 아세트산 310g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 92%의 폴리이미드(B-IPS1)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 36mPa·s였다. Next, 2,800 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 400 g of pyridine and 310 g of acetic anhydride were added, and dehydration ring-closure reaction was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with γ-butyrolactone, and then concentrated to obtain 2,300 g of a solution containing 15% by weight of polyimide (B-IPS1) having an imidization ratio of about 92%. The solution was aliquoted in small amounts, and the viscosity measured as the solution of 10 weight% of polyimide concentrations by adding (gamma) -butyrolactone was 36 mPa * s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-IPS2 Synthesis Example B-IPS2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰)을 이용한 것 이외는 합성예 B-IPS1과 동일하게 하여 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 35mPa·s였다. As the tetracarboxylic dianhydride, 112 g (0.50 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride were used. A polyamic acid solution was obtained in the same manner as in Synthesis example B-IPS1. A small amount of this solution was added, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 35 mPa · s.

이어서, 합성예 B-IPS1과 동일하게 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 94%의 폴리이미드(B-IPS2)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 34mPa·s였다. Subsequently, after performing dehydration ring-closure reaction similarly to the synthesis example B-IPS1, the solvent in a system is substituted by gamma-butyrolactone, and it concentrates then, the polyimide (B-IPS2) of about 94% of imidation ratio is obtained. 2300 g of solutions containing 15 weight% were obtained. The solution was aliquoted in small amounts, and the viscosity measured as a solution of 10 weight% of polyimide concentration by adding (gamma) -butyrolactone was 34 mPa * s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-IPS3 Synthesis Example B-IPS3

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 p-페닐렌디아민 97g(0.90몰) 및 4,4'-비스(트리플루오로메틸) 비페닐 32g(0.10몰)을 N-메틸-2-피롤리돈 2,000g에 용해하여, 40℃에서 3시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 46mPa·s였다. 112 g (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride and p- as diamine 97 g (0.90 mol) of phenylenediamine and 32 g (0.10 mol) of 4,4'-bis (trifluoromethyl) biphenyl were dissolved in 2,000 g of N-methyl-2-pyrrolidone and reacted at 40 ° C. for 3 hours. Was carried out to obtain a polyamic acid solution. The solution viscosity measured as a small amount of the obtained polyamic-acid solution, the addition of N-methyl- 2-pyrrolidone as a solution of 10 weight% of polymer concentrations, was 46 mPa * s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 2,700g을 추가하고, 피리딘 400g 및 무수 아세트산 310g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 93%의 폴리이미드(B-IPS3)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 42mPa·s였다. Subsequently, 2,700 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 400 g of pyridine and 310 g of acetic anhydride were added, and the dehydration ring-closure reaction was performed at 110 degreeC for 4 hours. After the dehydration ring-closure reaction, the solvent in the system was solvent-substituted with γ-butyrolactone, and then concentrated to give 2,300 g of a solution containing 15% by weight of polyimide (B-IPS3) having an imidization ratio of about 93%. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding γ-butyrolactone was 42 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 B-IPS4 Synthesis Example B-IPS4

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰)을 이용한 것 이외는 합성예 B-IPS3과 동일하게 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 35mPa·s였다. As the tetracarboxylic dianhydride, 112 g (0.50 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic dianhydride were used. Polyamic acid solution was obtained similarly to the synthesis example B-IPS3. A small amount of this solution was added, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 35 mPa · s.

이어서, 합성예 B-IPS3과 동일하게 하여 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 91%의 폴리이미드(B-IPS4)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 33mPa·s였다. Subsequently, after performing dehydration ring-closure reaction similarly to the synthesis example B-IPS3, the solvent in a system was solvent-substituted by (gamma) -butyrolactone, and it concentrated then polyimide (B-IPS4) of about 91% of imidation ratio. 2,300 g of a solution containing 15 wt% of was obtained. A small amount of this solution was added, and the solution viscosity measured as a solution having a polyimide concentration of 10% by weight by adding γ-butyrolactone was 33 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

[기타 폴리이미드의 합성예] [Synthesis example of other polyimide]

합성예 b-IPS5 Synthesis Example b-IPS5

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 220g(1.0몰)을 이용한 것 이외는 합성예 B-IPS1과 동일하게 하여 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 48mPa·s였다. A polyamic acid solution was obtained in the same manner as in Synthesis Example B-IPS1 except that 220 g (1.0 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride was used as tetracarboxylic dianhydride. A small amount of this solution was added, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 48 mPa · s.

이어서, 합성예 B-IPS1과 동일하게 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 93%의 폴리이미드(b-IPS5)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 45mPa·s였다. Subsequently, after performing dehydration ring-closure reaction similarly to the synthesis example B-IPS1, the solvent in a system is substituted by gamma-butyrolactone, and it concentrates, and the polyimide (b-IPS5) of about 93% of imidation ratio is then condensed. 2300 g of solutions containing 15 weight% were obtained. A small fraction of this solution was added, and the viscosity measured as a solution having a polyimide concentration of 10% by weight by adding γ-butyrolactone was 45 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

합성예 b-IPS6 Synthesis Example b-IPS6

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 220g(1.0몰)을 이용한 것 이외는 합성예 B-IPS4와 동일하게 하여 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 45mPa·s였다. A polyamic acid solution was obtained in the same manner as in Synthesis Example B-IPS4 except that 220 g (1.0 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride was used as tetracarboxylic dianhydride. A small amount of this solution was added, and the solution viscosity measured as a solution having a polymer concentration of 10% by weight by adding N-methyl-2-pyrrolidone was 45 mPa · s.

이어서, 합성예 B-IPS4와 동일하게 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 93%의 폴리이미드(b-IPS6)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 41mPa·s였다. Subsequently, after performing dehydration ring-closure reaction similarly to the synthesis example B-IPS4, the solvent in a system was solvent-substituted by (gamma) -butyrolactone, and it concentrated then, the polyimide (b-IPS6) of about 93% of imidation ratio was obtained. 2300 g of solutions containing 15 weight% were obtained. The solution was aliquoted in small portions, and the viscosity measured as a solution having a polyimide concentration of 10% by weight by adding γ-butyrolactone was 41 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. When this polymer solution was left to stand at 20 degreeC for 3 days, storage stability was favorable, without gelatinizing.

<TN형 액정 배향제의 조제 및 평가> <Preparation and evaluation of a TN type liquid crystal aligning agent>

실시예 TN-1 Example TN-1

(I) 액정 배향제의 조제 (I) Preparation of liquid crystal aligning agent

특정 중합체로서 상기 합성예 A-TN1에서 얻어진 폴리암산(A-TN1)을 함유하는 용액인 폴리암산(A-TN1)으로 환산하여 80중량부에 상당하는 양과, 기타 중합체로서 상기 합성예 b-TN2에서 얻어진 폴리이미드(b-TN2)를 함유하는 용액인 폴리이미드(b-TN2)로 환산하여 20중량부에 상당하는 양을 합하고, 이것에 N-메틸-2-피롤리돈(NMP), γ-부티로락톤(BL) 및 부틸셀로솔브(BC)를, 마지막 용매 조성이 NMP:BL:BC=17:71:12(중량비)가 되도록 더하고, 추가로 에폭시 화합물로서 N,N,N',N'-테트라글리시딜-4,4'-디아미노디페닐메탄을 2중량부를 더하여, 고형분 농도 3.5중량%의 용액을 조제했다. 이 용액을 충분히 교반 후, 공경(孔徑) 1㎛의 필터를 이용하여 여과함으로써, 액정 배향제를 조제했다. An amount equivalent to 80 parts by weight in terms of polyamic acid (A-TN1), which is a solution containing polyamic acid (A-TN1) obtained in Synthesis Example A-TN1, as a specific polymer, and Synthesis Example b-TN2 as another polymer The amount equivalent to 20 parts by weight in terms of polyimide (b-TN2), which is a solution containing polyimide (b-TN2) obtained in the above, was added, and N-methyl-2-pyrrolidone (NMP) and γ were added thereto. Butyrolactone (BL) and butyl cellosolve (BC) were added so that the final solvent composition was NMP: BL: BC = 17: 71: 12 (weight ratio), and further N, N, N 'as an epoxy compound. 2 weight part of and N'- tetraglycidyl-4,4'- diamino diphenylmethane were added, and the solution of 3.5 weight% of solid content concentration was prepared. After fully stirring this solution, the liquid crystal aligning agent was prepared by filtering using the filter of 1 micrometer of pore diameters.

(II) 액정 배향제의 평가 (II) Evaluation of the liquid crystal aligning agent

(1) TN형 액정 셀의 제조 (1) Preparation of TN type liquid crystal cell

상기에서 조제한 액정 배향제를, 액정 배향막 인쇄기(니혼샤신인사츠 가부시키가이샤 제조)를 이용하여 ITO막으로 이루어지는 투명 전극 부착 유리 기판의 투명 전극면에 도포하고, 80℃의 핫플레이트 상에서 1분간 가열(프리베이킹)하여 용매를 제거한 후, 200℃의 핫플레이트 상에서 10분간 가열(포스트베이킹)하여, 평균 막두께 600Å의 도막을 형성했다. The liquid crystal aligning agent prepared above is apply | coated to the transparent electrode surface of the glass substrate with a transparent electrode which consists of an ITO film using a liquid crystal aligning film printing machine (made by Nippon Shashin Inc.), and it heats on a 80 degreeC hotplate for 1 minute. (Prebaking) After removing a solvent, it heated on 10 degreeC hotplate for 10 minutes (postbaking), and formed the coating film of average film thickness of 600 Pa.

이 도막에 대하여, 레이온 천을 감은 롤을 갖는 러빙 머신에 의해, 롤 회전수 500rpm, 스테이지 이동 속도 3cm/초, 모족(毛足) 압입 길이 0.4mm에서 러빙 처리를 행하여, 액정 배향능을 부여했다. 그 후, 초순수 중에서 1분간 초음파 세정을 행하고, 이어서 100℃ 클린 오븐 안에서 10분간 건조함으로써, 액정 배향막을 갖는 기판을 얻었다. 이 조작을 반복하여, 액정 배향막을 갖는 기판을 한 쌍(2매) 얻었다. About this coating film, the rubbing process was performed by the rubbing machine which has the roll which wound the rayon cloth at roll rotation speed 500rpm, stage movement speed | rate 3cm / sec, and hairpin indentation length 0.4mm, and provided the liquid-crystal orientation ability. Thereafter, ultrasonic cleaning was performed in ultrapure water for 1 minute, and then dried in a 100 ° C clean oven for 10 minutes to obtain a substrate having a liquid crystal alignment film. This operation was repeated and the pair (2 sheets) of the board | substrate which has a liquid crystal aligning film was obtained.

다음으로, 상기 한 쌍의 기판 중 1매의 액정 배향막을 갖는 면의 외연(外緣)에, 직경 5.5㎛의 산화 알루미늄구 함유 에폭시 수지 접착제를 도포하고, 한 쌍의 기판을 액정 배향막면이 상대하도록 대향시켜 압착한 후, 접착제를 경화했다. 이어서, 액정 주입구로부터 한 쌍의 기판 간에, 네마틱형 액정(메르크사, MLC-6221)을 충전한 후, 아크릴계 광경화 접착제로 액정 주입구를 봉지함으로써, 액정 셀을 제조했다. Next, a 5.5-micrometer-diameter aluminum oxide containing epoxy resin adhesive is apply | coated to the outer edge of the surface which has one liquid crystal aligning film among the said pair of board | substrates, and a pair of board | substrates has a liquid crystal aligning film surface relative. The adhesive was hardened after opposing so that it might be pressed. Subsequently, after filling a nematic liquid crystal (Merck, MLC-6221) between a pair of board | substrates from a liquid crystal injection port, the liquid crystal cell was manufactured by sealing a liquid crystal injection port with an acryl-type photocuring adhesive.

(2) 내열 안정성의 평가 (2) Evaluation of heat stability

전압 보전율을 지표로 하여 열스트레스에 대한 내구성을 평가했다. 전압 보전율의 측정 장치로서는, 가부시키가이샤 토요테크니카 제조, 형식 「VHR-1」을 사용했다. The durability against heat stress was evaluated by using the voltage holding ratio as an index. As a measuring device of the voltage holding ratio, Toyo Technica Co., Ltd. make and model "VHR-1" were used.

상기에서 제조한 액정 셀에 대해서, 60℃에서, 액정 표시 소자에 5V의 전압을 60마이크로초의 인가 시간, 167밀리초의 스팬으로 인가한 후, 전압 인가 해제로부터 167밀리초 후에 전압 보전율을 측정했다(초기 전압 보전율 VHR0). About the liquid crystal cell manufactured above, after applying the voltage of 5V to 60 microseconds of application time and 167 milliseconds of span to a liquid crystal display element at 60 degreeC, voltage preservation rate was measured 167 milliseconds after voltage application release ( Initial Voltage Integrity VHR0).

이어서, 열스트레스 인가 전 전압 보전율 측정 후의 액정 표시 소자에 대해서, 100℃의 오븐 안에서 1,000시간 정치하여 열스트레스를 인가한 후, 상기와 동일하게 하여 재차 전압 보전율을 측정했다(열스트레스 인가 후 전압 보전율 VHR1). Subsequently, about the liquid crystal display element after voltage preservation rate measurement before thermal stress application, after standing still in an oven at 100 degreeC for 1,000 hours, and applying thermal stress, it carried out similarly to the above, and measured voltage preservation rate again (voltage preservation rate after heat stress application). VHR1).

상기에서 측정한 VHR0 및 VHR1의 값을 이용하여, 하기 수식 (1): Using the values of VHR0 and VHR1 measured above, the following formula (1):

ΔVHR=VHR0-VHR1 (1) ΔVHR = VHR0-VHR1 (1)

에 의해 열스트레스 인가 전후의 전압 보전율의 차이 △VHR을 구했다. 이 값이 5% 이내인 경우, 내열 안정성은 양호하다고 평가할 수 있다. The difference DELTA VHR of the voltage holding ratios before and after applying the thermal stress was obtained. When this value is within 5%, it can be evaluated that heat resistance is favorable.

평가 결과는 표 1에 나타냈다. The evaluation results are shown in Table 1.

실시예 TN-2 및 TN-3 그리고 비교예 tn-1 및 tn-2 Examples TN-2 and TN-3 and Comparative Examples tn-1 and tn-2

상기 실시예 TN-1에 있어서, 특정 중합체 및 기타 중합체로서, 각각 표 1에 기재된 종류 및 양의 중합체를 함유하는 용액을 사용하고, 각 용매를 마지막 용매 조성이 표 1에 기재한 바와 같이 되도록 더한 것 외는 실시예 TN-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. In the above Example TN-1, as a specific polymer and other polymers, solutions containing polymers of the kind and amount shown in Table 1, respectively, were used, and each solvent was added so that the final solvent composition was as shown in Table 1. Others were prepared and evaluated in the same manner as in Example TN-1 to prepare a liquid crystal aligning agent.

평가 결과는 표 1에 나타냈다. The evaluation results are shown in Table 1.

표 1 중의 「-」는, 당해 란에 해당하는 중합체를 사용하지 않았던 것을 나타낸다. 비교예 tn-1에서는, 기타 중합체로서 2종의 중합체를 혼합 사용했다. "-" In Table 1 shows that the polymer corresponding to the said column was not used. In Comparative Example tn-1, two kinds of polymers were mixed and used as other polymers.

표 1에 있어서의 용매의 약칭은, 각각 이하의 의미이다. The abbreviation of the solvent in Table 1 has the following meanings, respectively.

NMP: N-메틸-2-피롤리돈 NMP: N-methyl-2-pyrrolidone

BL: γ-부티로락톤 BL: γ-butyrolactone

BC: 부틸셀로솔브 BC: Butyl Cellosolve

Figure pat00003
Figure pat00003

<VA형 액정 배향제의 조제 및 평가> <Preparation and evaluation of a VA type liquid crystal aligning agent>

실시예 VA-1 Example VA-1

(I) 액정 배향제의 조제 (I) Preparation of liquid crystal aligning agent

중합체로서, 상기 합성예 B-VA1에서 얻어진 폴리이미드(B-VA1)를 함유하는 용액에 N-메틸-2-피롤리돈 및 부틸셀로솔브를 더하고, 추가로 에폭시 화합물로서 N,N,N',N'-테트라글리시딜-m-자일렌디아민을, 사용한 폴리이미드 100중량부에 대하여 5중량부 더하고 충분히 교반하여, 용매 조성이 N-메틸-2-피롤리돈:부틸셀로솔브=50:50(중량비), 고형분 농도 3.5중량%의 용액으로 했다. 이 용액을 공경 1㎛의 필터를 이용하여 여과함으로써, 액정 배향제를 조제했다. As a polymer, N-methyl-2-pyrrolidone and butyl cellosolve were added to a solution containing the polyimide (B-VA1) obtained in Synthesis Example B-VA1, and further N, N, N as an epoxy compound. 5 weight part of ', N'- tetraglycidyl-m-xylenediamine is added with respect to 100 weight part of used polyimides, and it fully stirs and a solvent composition N-methyl- 2-pyrrolidone: butyl cellosolve It was set as the solution of = 50: 50 (weight ratio) and solid content concentration 3.5 weight%. The liquid crystal aligning agent was prepared by filtering this solution using the filter of 1 micrometer of pore diameters.

(II) 액정 배향제의 평가 (II) Evaluation of the liquid crystal aligning agent

(1) VA형 액정 셀의 제조 (1) Preparation of VA type liquid crystal cell

두께 1mm의 유리 기판의 편면에 형성된 ITO막으로 이루어지는 투명 도전막 상에, 상기에서 조제한 액정 배향제를 스피너에 의해 도포하고, 핫플레이트 상 80℃에서 1분간의 프리베이킹을 행하고, 이어서 핫플레이트 상 210℃에서 30분간 포스트베이킹함으로써, 막두께 80nm의 도막(액정 배향막)을 형성했다. 이 조작을 반복하여, 액정 배향막을 갖는 기판을 2매(한 쌍) 얻었다. On the transparent conductive film which consists of an ITO film formed on the single side | surface of the glass substrate of thickness 1mm, the liquid crystal aligning agent prepared above was apply | coated with a spinner, prebaking was carried out for 1 minute at 80 degreeC on a hotplate, and then hotplate phase By post-baking at 210 degreeC for 30 minutes, the coating film (liquid crystal aligning film) of 80 nm in film thickness was formed. This operation was repeated and two pieces (pair) of board | substrates which have a liquid crystal aligning film were obtained.

다음으로, 상기 한 쌍의 기판 중 1매의 액정 배향막을 갖는 면의 외연에, 직경 3.5um의 산화 알루미늄구 함유 에폭시 수지 접착제를 도포하고, 한 쌍의 기판을 각 액정 배향막이 상대하도록 대향시켜 압착한 후, 접착제를 경화했다. 이어서, 액정 주입구로부터 기판 간에, 네거티브형 액정(메르크사 제조, MLC-6608)을 충전한 후, 아크릴계 광경화 접착제로 액정 주입구를 봉지하여, 액정 셀을 제조했다. Next, an aluminum oxide sphere-containing epoxy resin adhesive having a diameter of 3.5 μm is applied to the outer edge of the surface having one liquid crystal alignment film among the pair of substrates, and the pair of substrates are faced to face each other so that the liquid crystal alignment films face each other. After that, the adhesive was cured. Subsequently, after filling a negative liquid crystal (MLC-6608 by Merck Co., Ltd.) between board | substrates from a liquid crystal injection port, the liquid crystal injection port was sealed with the acryl-type photocuring adhesive agent, and the liquid crystal cell was produced.

(2) 내열 안정성의 평가 (2) Evaluation of heat stability

상기에서 제조한 액정 셀을 이용하여, 상기 실시예 TN-1과 동일하게 하여 내열 안정성의 평가를 했다. 단, VA형의 액정 셀의 경우, 열스트레스 인가 전후의 전압 보전율의 차이 △VHR의 값이 2% 이내인 경우에 내열 안정성은 양호하다고 평가할 수 있다. Using the liquid crystal cell produced above, heat resistance stability was evaluated in the same manner as in Example TN-1. However, in the case of the VA type liquid crystal cell, the heat resistance stability can be evaluated to be good when the value of the difference? VHR of the voltage holding ratio before and after heat stress is within 2%.

평가 결과는 표 2에 나타냈다. The evaluation results are shown in Table 2.

실시예 VA-2∼VA-6 그리고 비교예 va-1 및 va-2 Examples VA-2 to VA-6 and Comparative Examples va-1 and va-2

상기 실시예 VA-1에 있어서, 중합체로서 각각 표 2에 기재된 중합체를 함유하는 용액을 사용한 것 외는 실시예 VA-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. In the said Example VA-1, the liquid crystal aligning agent was prepared and evaluated similarly to Example VA-1 except having used the solution containing the polymer of Table 2 as a polymer, respectively.

평가 결과는 표 2에 나타냈다. The evaluation results are shown in Table 2.

표 2 중의 「-」는, 당해 란에 해당하는 중합체를 사용하지 않았던 것을 나타낸다. "-" In Table 2 shows that the polymer corresponding to the said column was not used.

표 2에 있어서의 용매의 약칭은, 표 1의 경우와 동일하다. The abbreviation of the solvent in Table 2 is the same as that of Table 1.

Figure pat00004
Figure pat00004

<IPS형 액정 배향제의 조제 및 평가> <Preparation and evaluation of IPS type liquid crystal aligning agent>

실시예 IPS-1 Example IPS-1

(I) 액정 배향제의 조제 (I) Preparation of liquid crystal aligning agent

중합체로서 상기 합성예 A-IPS1에서 얻어진 폴리암산(A-IPS1)을 함유하는 용액에 용매로서, N-메틸-2-피롤리돈 및 부틸셀로솔브를 더하고, 추가로 에폭시 화합물로서 N,N,N',N'-테트라글리시딜-m-자일렌디아민을, 사용한 폴리암산 100중량부에 대하여 5중량부 더하여 충분히 교반하여, 용매 조성이 N-메틸-2-피롤리돈:부틸셀로솔브=80:20(중량비), 고형분 농도 3.5중량%의 용액으로 했다. 이 용액을 공경 1㎛의 필터를 이용하여 여과함으로써, 액정 배향제를 조제했다. To the solution containing polyamic acid (A-IPS1) obtained in Synthesis Example A-IPS1 as a polymer, N-methyl-2-pyrrolidone and butyl cellosolve are added as a solvent, and N, N as an epoxy compound is further added. 5 parts by weight of, N ', N'-tetraglycidyl-m-xylenediamine is added to 100 parts by weight of the polyamic acid used, and the mixture is sufficiently stirred. The solvent composition is N-methyl-2-pyrrolidone: butyl cell. Low solution = 80:20 (weight ratio) and solid content concentration were used as the solution of 3.5 weight%. The liquid crystal aligning agent was prepared by filtering this solution using the filter of 1 micrometer of pore diameters.

(II) 액정 배향제의 평가 (II) Evaluation of the liquid crystal aligning agent

(1) 액정 셀의 제조 (1) Preparation of liquid crystal cell

상기에서 조제한 액정 배향제를 이용한 것 외는 실시예 TN-1에 있어서의 것과 동일하게 하여 액정 셀을 제조하여, 내열 안정성의 평가를 행했다. The liquid crystal cell was produced like the thing in Example TN-1 except having used the liquid crystal aligning agent prepared above, and the heat resistance stability was evaluated.

평가 결과는 표 3에 나타냈다. The evaluation results are shown in Table 3.

또한, 여기에서 제조한 액정 셀은 TN형 액정 셀이지만, IPS형 액정 셀의 내열 안정성 평가용 시료로서 TN형 액정 셀을 대체적(代替的)으로 이용할 수 있는 것을, 본 발명자들은 경험적으로 확인하고 있다. In addition, although the liquid crystal cell manufactured here is a TN type liquid crystal cell, the present inventors have empirically confirmed that a TN type liquid crystal cell can be used as a sample for heat stability stability evaluation of an IPS type liquid crystal cell. .

실시예 IPS-2∼IPS-5 및 비교예 ips-1∼ips-3 Examples IPS-2 to IPS-5 and Comparative Examples ips-1 to ips-3

상기 실시예 IPS-1에 있어서, 중합체로서 각각 표 3에 기재된 중합체를 함유하는 용액을 사용한 것 외는 실시예 IPS-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. In the said Example IPS-1, the liquid crystal aligning agent was prepared and evaluated similarly to Example IPS-1 except having used the solution containing the polymer of Table 3 as a polymer, respectively.

평가 결과는 표 3에 나타냈다. The evaluation results are shown in Table 3.

실시예 IPS-6∼9 그리고 비교예 ips-4 및 ips-5 Examples IPS-6-9 and Comparative Examples ips-4 and ips-5

상기 실시예 IPS-1에 있어서, 중합체로서 각각 표 3에 기재된 중합체를 함유하는 용액을, 용매로서 N-메틸-2-피롤리돈(NMP), γ-부티로락톤(BL) 및 부틸셀로솔브(BC)를 각각 사용하여, 이들 각 용매를 마지막 용매 조성이 NMP:BL:BC= 10:70:20(중량비)이 되도록 더한 것 외는, 실시예 IPS-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. In Example IPS-1, a solution containing the polymers listed in Table 3 as polymers, respectively, was used as N-methyl-2-pyrrolidone (NMP), γ-butyrolactone (BL), and butylcell as solvents. A liquid crystal aligning agent was prepared in the same manner as in Example IPS-1 except that each of these solvents was added so that the final solvent composition was NMP: BL: BC = 10: 70: 20 (weight ratio) using a solution (BC). It prepared and evaluated.

평가 결과는 표 3에 나타냈다. The evaluation results are shown in Table 3.

표 3 중의 「-」는, 당해 란에 해당하는 중합체를 사용하지 않았던 것을 나타낸다. "-" In Table 3 shows that the polymer corresponding to the said column was not used.

표 3에 있어서의 용매의 약칭은, 표 1의 경우와 동일하다. The abbreviation of the solvent in Table 3 is the same as that of Table 1.

Figure pat00005
Figure pat00005

Claims (6)

테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제로서,
상기 테트라카본산 2무수물이, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종을, 전체 테트라카본산 2무수물에 대하여 5∼80몰% 포함하는 것을 특징으로 하는 상기 액정 배향제.
As a liquid crystal aligning agent containing at least 1 sort (s) of polymer chosen from the group which consists of polyamic acid obtained by making tetracarboxylic dianhydride and diamine react, and the polyimide formed by dehydrating and closing the said polyamic acid,
The tetracarboxylic dianhydride is at least one selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride, It contains 5-80 mol% with respect to the total tetracarboxylic dianhydride, The said liquid crystal aligning agent characterized by the above-mentioned.
제1항에 있어서,
상기 테트라카본산 2무수물이, 1,2,3,4-사이클로부탄테트라카본산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물, 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 3-옥사바이사이클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라하이드로푸란-2',5'-디온), 5-(2,5-디옥소테트라하이드로-3-푸라닐)-3-메틸-3-사이클로헥센-1,2-디카본산 무수물, 3,5,6-트리카복시-2-카복시메틸노르보르난-2:3,5:6-2무수물, 2,4,6,8-테트라카복시바이사이클로[3.3.0]옥탄-2:4,6:8-2무수물 및 4,9-디옥사트리사이클로[5.3.1.02,6]운데칸-3,5,8,10-테트라온으로 이루어지는 군으로부터 선택되는 적어도 1종을 추가로 포함하는 것인 액정 배향제.
The method of claim 1,
The tetracarboxylic dianhydride is 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic dianhydride, 1,3,3a, 4,5,9b- Hexahydro-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 1,3,3a, 4,5,9b -Hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 3-oxabicyclo [ 3.2.1] octane-2,4-dione-6-spiro-3 '-(tetrahydrofuran-2', 5'-dione), 5- (2,5-dioxotetrahydro-3-furanyl) -3-methyl-3-cyclohexene-1,2-dicarboxylic acid anhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornane-2: 3,5: 6-2 anhydride, 2,4, 6,8-tetracarboxybicyclo [3.3.0] octane-2: 4,6: 8-2 anhydride and 4,9-dioxatricyclo [5.3.1.0 2,6 ] undecane-3,5,8 The liquid crystal aligning agent which further contains at least 1 sort (s) chosen from the group which consists of a 10- tetraone.
제1항에 있어서,
상기 디아민이, p-페닐렌디아민, 3,5-디아미노벤조산, 4,4'-디아미노디페닐에테르, 4,4'-디아미노디페닐메탄, 2,2'-디메틸-4,4'-디아미노비페닐, 4,4'-디아미노-2,2'-비스(트리플루오로메틸)비페닐, 4,4'-디아미노디페닐아민 및 4,4'-(m-페닐렌디이소프로필리덴)디아닐린으로 이루어지는 군으로부터 선택되는 적어도 1종을 포함하는 것인 액정 배향제.
The method of claim 1,
P-phenylenediamine, 3, 5- diamino benzoic acid, 4,4'- diamino diphenyl ether, 4,4'- diamino diphenylmethane, 2,2'- dimethyl- 4,4 '-Diaminobiphenyl, 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, 4,4'-diaminodiphenylamine and 4,4'-(m-phenyl The liquid crystal aligning agent containing at least 1 sort (s) chosen from the group which consists of a lendiisopropylidene) dianiline.
제1항 내지 제3항 중 어느 한 항에 있어서,
분자 내에 적어도 1개의 에폭시기를 갖는 화합물을 추가로 함유하는 액정 배향제.
4. The method according to any one of claims 1 to 3,
The liquid crystal aligning agent which further contains the compound which has at least 1 epoxy group in a molecule | numerator.
제1항 내지 제3항 중 어느 한 항에 기재된 액정 배향제로 형성된 것을 특징으로 하는 액정 배향막. It formed with the liquid crystal aligning agent in any one of Claims 1-3, The liquid crystal aligning film characterized by the above-mentioned. 제5항에 기재된 액정 배향막을 구비하는 것을 특징으로 하는 액정 표시 소자. The liquid crystal aligning film of Claim 5 is provided, The liquid crystal display element characterized by the above-mentioned.
KR1020110003538A 2010-01-19 2011-01-13 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device KR101798375B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010008948 2010-01-19
JPJP-P-2010-008948 2010-01-19

Publications (2)

Publication Number Publication Date
KR20110085891A true KR20110085891A (en) 2011-07-27
KR101798375B1 KR101798375B1 (en) 2017-12-12

Family

ID=44265735

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020110003538A KR101798375B1 (en) 2010-01-19 2011-01-13 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device

Country Status (4)

Country Link
JP (1) JP5849391B2 (en)
KR (1) KR101798375B1 (en)
CN (1) CN102127459B (en)
TW (1) TWI504675B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6079627B2 (en) * 2011-07-12 2017-02-15 日産化学工業株式会社 Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
JP5691996B2 (en) * 2011-10-21 2015-04-01 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5845918B2 (en) * 2012-01-20 2016-01-20 宇部興産株式会社 Polyimide precursor and polyimide
JP5884979B2 (en) * 2012-03-09 2016-03-15 Jsr株式会社 (1R, 2S, 4S, 5R) Method for producing cyclohexanetetracarboxylic dianhydride
KR20200105976A (en) * 2012-11-16 2020-09-09 닛산 가가쿠 가부시키가이샤 Polyimide resin film and electronic-device substrate comprising polyimide resin film
WO2014080865A1 (en) * 2012-11-21 2014-05-30 Jsr株式会社 Liquid crystal orientation agent, liquid crystal orientation membrane and method for manufacturing same, and liquid crystal display element
CN105814116A (en) * 2013-10-11 2016-07-27 宇部兴产株式会社 Polyimide precursor, polyimide, polyimide film, varnish, and substrate
JP6557963B2 (en) * 2014-02-25 2019-08-14 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6596931B2 (en) * 2014-08-29 2019-10-30 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6579110B2 (en) * 2014-10-17 2019-09-25 三菱瓦斯化学株式会社 Polyimide resin composition, polyimide film and laminate
CN111647412A (en) * 2020-06-12 2020-09-11 江苏三月科技股份有限公司 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61238809A (en) * 1985-04-16 1986-10-24 Ube Ind Ltd Liquid photosensitive polyimide resin composition
TWI283783B (en) * 1999-12-09 2007-07-11 Jsr Corp Liquid crystal alignment film and liquid crystal display device
JP2002062537A (en) * 2000-08-21 2002-02-28 Jsr Corp Liquid crystal aligning agent for stn (supertwisted nematic) liquid crystal display element and stn liquid crystal display element
JP2002155139A (en) * 2000-11-22 2002-05-28 Hitachi Cable Ltd Solvent-soluble block polyimide composition for liquid crystal orientated film and its manufacturing method
JP4375533B2 (en) * 2003-06-26 2009-12-02 三菱瓦斯化学株式会社 Method for producing solvent-soluble polyimide
JP5120047B2 (en) * 2007-05-02 2013-01-16 Jsr株式会社 Vertical alignment type liquid crystal aligning agent and liquid crystal display element
JP5077048B2 (en) * 2007-05-02 2012-11-21 Jsr株式会社 Vertical alignment type liquid crystal alignment agent
JP2008297360A (en) * 2007-05-29 2008-12-11 New Japan Chem Co Ltd Solvent-soluble polyimide resin
JP5315496B2 (en) * 2008-01-18 2013-10-16 和光純薬工業株式会社 Novel (1S, 2S, 4R, 5R) -cyclohexanetetracarboxylic dianhydride and use thereof
JP5325460B2 (en) * 2008-05-27 2013-10-23 和光純薬工業株式会社 Novel (1R, 2S, 4S, 5R) -cyclohexanetetracarboxylic dianhydride and use thereof
JP2009294281A (en) * 2008-06-03 2009-12-17 Jsr Corp Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP5325491B2 (en) * 2008-08-01 2013-10-23 株式会社カネカ Novel coating type optical compensation film and method for producing the same
JP2010070721A (en) * 2008-09-22 2010-04-02 Sekisui Chem Co Ltd Polyimide and method of producing the same
JP5630139B2 (en) * 2009-08-18 2014-11-26 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Also Published As

Publication number Publication date
CN102127459B (en) 2015-09-16
TW201132703A (en) 2011-10-01
KR101798375B1 (en) 2017-12-12
JP2011170321A (en) 2011-09-01
TWI504675B (en) 2015-10-21
JP5849391B2 (en) 2016-01-27
CN102127459A (en) 2011-07-20

Similar Documents

Publication Publication Date Title
JP5668904B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5273357B2 (en) Liquid crystal aligning agent and liquid crystal display element
KR101798375B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
JP5783023B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101923080B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
JP5569441B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5057074B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5582295B2 (en) Liquid crystal aligning agent and liquid crystal display element
KR101543796B1 (en) Liquid crystal aligning agent liquid crystal alignment film and liquid crystal display device
JP5071662B2 (en) Liquid crystal aligning agent and liquid crystal display element
KR20090100274A (en) Liquid crystal aligning agent and liquid crystal display device
JP5633667B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR20130097649A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
KR20130044141A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
JP5962381B2 (en) Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element and polymer
KR101746043B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
JP2009229935A (en) Liquid crystal aligning agent and liquid crystal display element
JP6315193B2 (en) Liquid crystal alignment agent
KR101828824B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
KR20110030310A (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device, and polymers contained therein
JP2012173453A (en) Liquid crystal aligning agent and liquid crystal display element
JP2011018022A (en) Liquid crystal aligning agent and liquid crystal display element
JP2009294281A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
KR101894831B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
TWI666232B (en) Liquid crystal alignment agent and production method thereof, liquid crystal alignment film and production method thereof, and liquid crystal display element

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant